Satisfaction with analgesic therapy in patients with rheumatic diseases in real clinical practice, according to the KOMPAS study (Quality of Pain Relief in the Opinion of Patients with Arthritis and Back Pain) ; Удовлетворенность обезболивающей терапией пациентов с ревматическими заболеваниями в реальной клинической практике, по данным исследования КОМПАС (Качество Обезболивания по Мнению Пациентов с Артритом и болью в Спине)

Συγγραφείς: E. Yu. Pogozheva, A. E. Karateev, N. A. Bulgakova, V. N. Amirdzhanova, E. S. Filatova, V. A. Nesterenko, A. M. Lila, Е. Ю. Погожева, А. Е. Каратеев, Н. А. Булгакова, В. Н. Амирджанова, Е. С. Филатова, В. А. Нестеренко, А. М. Лила

Πηγή: Modern Rheumatology Journal; Том 15, № 4 (2021); 43-49 ; Современная ревматология; Том 15, № 4 (2021); 43-49 ; 2310-158X ; 1996-7012

Θεματικοί όροι: удовлетворенность лечением, pain, analgesic therapy, satisfaction with treatment, боль, анальгетическая терапия

Περιγραφή αρχείου: application/pdf

Relation: https://mrj.ima-press.net/mrj/article/view/1169/1126; Лила АМ, Древаль РО, Инамова ОВ и др. Медико-экономический анализ влияния инвалидизации, ассоциированной с ревматическими заболеваниями, на экономику страны с учетом реализации пенсионной реформы. Современная ревматология. 2019;13(4):18-25. doi:10.14412/1996-7012-2019-4-18-25; Lwin MN, Serhal L, Holroyd C, Edwards CJ. Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. Rheumatol Ther. 2020 Sep;7(3):457-71. doi:10.1007/s40744020-00217-4; Mpinga EK, Chastonay P. Satisfaction of patients: a right to health indicator? Health Policy. 2011 May;100(2-3):144-50. doi:10.1016/j.healthpol.2010.11.001. Epub 2010 Dec 3.; Batbaatar E, Dorjdagva J, Luvsannyam A, Amenta P. Conceptualisation of patient satisfaction: a systematic narrative literature review. Perspect Public Health. 2015 Sep; 135(5):243-50. doi:10.1177/1757913915594196. Epub 2015 Jul 17.; Taylor PC, Ancuta C, Nagy O, et al. Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study. Patient Prefer Adherence. 2021 Feb 17;15:359-73. doi:10.2147/PPA.S289692. eCollection 2021.; Payne VL, Singh H, Meyer AN, et al. Patient-initiated second opinions: systematic review of characteristics and impact on diagnosis, treatment, and satisfaction. Mayo Clin Proc. 2014 May;89(5):687-96. doi:10.1016/j.mayocp.2014.02.015.; Gore M, Sadosky A, Leslie D, et al. Therapy Switching, Augmentation, and Discontinuation in Patients with Osteoarthritis and Chronic Low Back Pain. Pain Pract. 2012 Jul;12(6):457-68. doi:10.1111/j.1533-2500.2011.00524.x. Epub 2012 Jan 9.; Makris UE, Abrams RC, Gurland B, Reid MC. Management of persistent pain in the older patient: a clinical review. JAMA. 2014 Aug 27;312(8):825-36. doi:10.1001/jama.2014.9405.; Anghel LA, Farcas AM, Oprean RN. Medication adherence and persistence in patients with autoimmune rheumatic diseases: a narrative review. Patient Prefer Adherence. 2018 Jul 3;12:1151-66. doi:10.2147/PPA.S165101.; Häuser W, Schmutzer G, Henningsen P, Brähler E. Chronic pain, pain disease, and satisfaction of patients with pain treatment in Germany. Results of a representative population survey. Schmerz. 2014 Oct;28(5):483-92. doi:10.1007/s00482-014-1438-y.; Todd K, Cowan P, Kelly N, Homel P. Chronic or recurrent pain in the emergency department: national telephone survey of patient experience. West J Emerg Med. 2010 Dec;11(5):408-15.; Kone V, Lecomte F, Randriamanana D, et al. Impact of a pilot team on patients' pain reduction and satisfaction in an emergency department: A before-and-after observational study. Rev Epidemiol Sante Publique. 2016 Apr;64(2):59-66. doi:10.1016/j.respe.2015.11.010.; Taylor S, Everett S, Taylor T, et al. A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control. Open Access Rheumatol. 2013 Jul 29;5:69-76. doi:10.2147/OARRR.S41940.; Gossec L, Molto A, Romand X, et al. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. Joint Bone Spine. 2019 Jan;86(1):13-19. doi:10.1016/j.jbspin.2018.08.006.; Margolis JM, Princic N, Smith DM, et al. Development of a novel algorithm to determine adherence to chronic pain treatment guidelines using administrative claims. J Pain Res. 2017 Feb 8;10:327-39. doi:10.2147/JPR.S118248.; Efthimiou P, Kukar M. Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol Int. 2010 Mar;30(5):571-86. doi:10.1007/s00296-009-1206-y; Casale R, Atzeni F, Bazzichi L, et al. Pain in Women: A Perspective Review on a Relevant Clinical Issue that Deserves Prioritization. Pain Ther. 2021 Jun;10(1): 287-314. doi:10.1007/s40122-021-00244-1. Epub 2021 Mar 15.; Courties A, Gualillo O, Berenbaum F, Sellam J. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage. 2015 Nov;23(11):1955-65. doi:10.1016/j.joca.2015.05.016.; Belluzzi E, El Hadi H, Granzotto M, et al. Systemic and Local Adipose Tissue in Knee Osteoarthritis. J Cell Physiol. 2017 Aug; 232(8):1971-8. doi:10.1002/jcp.25716.; Pincus T, Castrejon I, Yazici Y, et al. Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease. Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):7-17.; Яхно НН, Кукушкин МЛ, редакторы. Боль (практическое руководство для врачей). Москва: Издательство РАМН; 2012. 512 c.; Larsson C, Hansson EE, Sundquist K, Jakobsson U. Chronic pain in older adults: prevalence, incidence, and risk factors. Scand J Rheumatol. 2016 Nov 25:1-9. doi:10.1080/03009742.2016.1218543.; Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005 Sep; 17(5):624-8. doi:10.1097/01.bor.0000172800.49120.97.; Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011 Dec;13(6):513-20. doi:10.1007/s11926-0110206-6.; Haviv B, Bronak S, Thein R. The complexity of pain around the knee in patients with osteoarthritis. Isr Med Assoc J. 2013 Apr;15(4):178-81.

Διαθεσιμότητα: https://mrj.ima-press.net/mrj/article/view/1169
https://doi.org/10.14412/1996-7012-2021-4-43-49

CYTOKINE GENE POLYMORPHISMS AS PREDICTORS OF CHRONIC PAIN SYNDROME IN ONCOLOGY ; ГЕНЕТИЧЕСКИЙ ПОЛИМОРФИЗМ ЦИТОКИНОВ КАК ПРЕДИКТОР ФЕНОТИПИЧЕСКОЙ РЕАЛИЗАЦИИ ХРОНИЧЕСКОГО БОЛЕВОГО СИНДРОМА В ОНКОЛОГИИ

Συγγραφείς: O. P. Bobrova, N. A. Shnayder, M. M. Petrova, K. S. Zyryanov, D. A. Sychev, О. П. Боброва, Н. А. Шнайдер, М. М. Петрова, С. К. Зырянов, Д. А. Сычев

Πηγή: Siberian journal of oncology; Том 16, № 5 (2017); 87-94 ; Сибирский онкологический журнал; Том 16, № 5 (2017); 87-94 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2017-16-5

Θεματικοί όροι: цитокиновые рецепторы, oncology, single nucleotide polymorphisms (SNPs), analgesic therapy, review, TNF-α, IL-1, IL-6, IL-10, pharmacogenetics, nociception, cytokine receptors, онкология, однонуклеотидный полиморфизм (ОНП), анальгетическая терапия, обзор, ФНО-α, фармакогенетика, ноцицепция

Περιγραφή αρχείου: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/617/479; Микаэлян М.Ф., Аджиенко В.Л. Концепции и проблемы лечения хронического болевого синдрома на современном этапе. Лекарствен- ный вестник. 2016; 2 (62): 28–30.; Яхно Н.Н., Кукушкина М.Л. Боль (практическое руководство для врачей). М.: Изд-во РАМН, 2011; 512.; Балашова Т.В., Андреева Н.А., Мнацаканяни Л.А., Котельнико- ва А.Г., Долгунов А.М. Современные представления о патогенезе боли. Тихоокеанский медицинский журнал. 2012; 3: 13–16.; Wang X.B., Li Y.S., Li J., Han Y., Liu Z.D. Interleukin-8 -251A/T gene polymorphism and lung cancer susceptibility: a meta-analysis. J Cell Mol Med. 2015 Jun; 19 (6): 1218–22. doi:10.1111/jcmm.12466.; Schmidt B.L., Hamamoto D.T., Simone D.A., Wilcox G.L. Mechanisms of cancer pain. J Mol Interv. 2010; 10 (3): 164–78. doi:10.1124/mi.10.3.7.; Yoneda T., Hata K., Nakanishi M., Nagae M., Nagayama T., Wakabayashi H., Nishisho T., Sakurai T., Hiraga T. Involvement of acidic microenvironment in the pathophysiology of cancer-associated bone pain. Bone. 2011; 48 (1): 100–5. doi:10.1016/j.bone.2010.07.009.; Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140(6): 88399. doi:10.1016/j.cell.2010.01.025.; Матвеева Л.В., Мосина Л.М. Роль цитокинов семейства интерлейкина-1 в желудочном канцерогенезе. Вестник РАМН. 2012; 11: 59–65.; Branford R., Droney J., Ross J.R. Opioid genetics: the key to personalized pain control? Clin Genet. 2012; 82: 301–310. doi:10.1111/j.1399- 0004.2012.01923.x.; Neeb L., Hellen P., Boehnke C., Hoffmann J., Schuh-Hofer S., Dirnagl U., Reuter U. IL-1beta stimulates COX-2 dependent PGE synthesis and CGRP release in rat trigeminal ganglia cells. PLoS One. 2011; 6 (3): e17360. doi:10.1371/journal.pone.0017360.; Hirata H., Tetsumoto S., Kijima T., Kida H., Kumagai T., Takahashi R., Otani Y., Inoue K., Kuhara H., Shimada K., Nagatomo I., Takeda Y., Goya S., Yoshizaki K., Kawase I., Tachibana I., Kishimoto T., Kumanogoh A. Favorable responses to tocilizumab in two patients with cancer – related cachexia. J Pain Symptom Manage. 2013; 46 (2): e9–e13. doi:10.1016/j.jpainsymman.2013.01.009.; Wang X.M., Lehky T.J., Brell J.M., Dorsey S.G. Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine. 2012; 59 (1): 3–9. doi:10.1016/j.cyto.2012.03.027.; Guo G., Gao F. CXCR3: latest evidence for the in volvemen to chemokine signaling in bone cancer pain. Exp Neurol. 2015; 265: 1769. doi:10.1016/j.expneurol.2015.02.003.; Vendrell D., Macedo I., Alho M., Dionísio R., Costa L. Treatment of cancer pain by targeting cytokines. Mediators Inflamm. 2015; 2015: 984570. doi:10.1155/2015/984570.; Jaggi A.S., Singh N. Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy. Toxicology. 2012; 291 (1–3): 1–9. doi:10.1016/j.tox.2011.10.019.; Saijo Y., Tanaka M., Miki M., Usui K., Suzuki T., Maemondo M., Hong X., Tazawa R., Kikuchi T., Matsushima K., Nukiwa T. Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J Immunol. 2002; 169: 469–475.; Kiguchi N., Kobayashi Y., Kishioka S. Chemokine and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol. 2012; 12 (1): 55–61. doi:10.1016/j.coph.2011.10.007.; Guan X.H., Fu Q.C., Shi D., Bu H.L., Song Z.P., Xiong B.R., Shu B., Xiang H.B., Xu B., Manyande A., Cao F., Tian Y.K. Activation of spinal chemokine receptor CXCR3 mediates bonecancer pain throughanAkt ERKcross talk pathway in rats. Exp Neurol. 2015 Jan; 263: 39–49. doi:10.1016/j.expneurol.2014.09.019.; Doong S.H., Dhruva A., Dunn L.B., West C., Paul S.M., Cooper B.A., Elboim C., Abrams G., Merriman J.D., Langford D.J., Leutwyler H., Baggott C., Kober K., Aouizerat B.E., Miaskowski C. Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs. 2015; 17 (3): 23747. doi:10.1177/1099800414550394.; Reyes-Gibby C.C., Shete S., Yennurajalingam S., Frazier M., Bruera E., Kurzrock R., Crane C.H., Abbruzzese J., Evans D., Spitz M.R. Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage. 2009; 38 (6): 894–902.doi:10.1016/j. jpainsymman.2009.04.019.; Luo M., Yang Y., Luo D., Liu L., Zhang Y., Xiao F., Yang J., Zhang C., FuS., Luo Z. Tumor necrosis factor-alpha promoter polymorphism 308 G/A is not significantly associated with esophageal cancer risk: a meta-analysis. Oncotarget. 2016; 7 (48): 79901–13. doi:10.18632/oncotarget.13093.; Bandil K., Singhal P., Sharma U., Hussain S., Basu S., Parashari A., Singh V., Sehgal A., Shivam A., Ahuja P., Bharadwaj M., Banerjee B.D., Mehrotra R. Impacts of TNF-LTA SNPs/Haplotypes and Lifestyle Factors on Oral Carcinoma in an Indian Population. Mol Diagn Ther. 2016; 20 (5): 469–80. doi:10.1007/s40291-016-0215-2.; Zhao H., Zhang H.W., Zhang T., Gu X.M. Tumor necrosis factor alpha gene -308G>A polymorphism association with the risk of esophageal cancer in a Han Chinese population. Genet Mol Res. 2016 Oct 7; 15 (4). doi:10.4238/gmr.150458661.; Reyes-Gibby C.C., Spitz M.R., Yennurajalingam S., Swartz M., Gu J., Wu X., Bruera E., Shete S. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009; 18 (10): 2636–2642. doi:10.1158/1055-9965.EPI-09-0426.; Sun Q., Guo X., Wang Q., Zhao F. The association of TNF-308 (G/A) gene polymorphisms and hepatocellular carcinoma risk: a metaanalysis. Chin J Cancer Res. 2016; 28 (5): 536–542. doi:10.21147/j. issn.1000-9604.2016.05.09.; Rausch S.M., Gonzalez B.D., Clark M.M., Patten C., Felten S., Liu H., Li Y., Sloan J., Yang P. SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors. Lung Cancer. 2012; 77 (1): 217–23. doi:10.1016/j.lungcan.2012.02.017.; Wang Z., Liu Y., Yang L., Yin S., Zang R., Yang G. The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis. Tumour Biol. 2014; 35 (7): 7115–23. doi:10.1007/s13277-014-1881-5.; Baune B.T., Dannlowski U., Domschke K., Janssen D.G., Jordan M.A., Ohrmann P., Bauer J., Biros E., Arolt V., Kugel H., Baxter A.G., Suslow T. The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression. Biol Psychiatry. 2010; 67 (6): 543–9. doi:10.1016/j. biopsych.2009.11.004; Reyes-Gibby C.C., Spitz M., Wu X., Merriman K., Etzel C., Bruera E., Kurzrock R., Shete S. Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev. 2007; 16 (12): 2745–2751. doi:10.1158/1055-9965.epi-07-0651.; Reyes Gibby C.C., Spitz M.R., Yennurajalingam S., Swartz M., Gu J., Wu X., Bruera E., Shete S. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2009; 18 (10): 2636–42. doi:10.1158/1055-9965.EPI-09-0426.; Müerköster S., Wegehenkel K., Arlt A., Witt M., Sipos B., Kruse M.L., Sebens T., Klöppel G., Kalthoff H., Fölsch U.R., Schäfer H. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res. 2004; 64: 1331–1337.; Gan W.Y., Li H.M., Zhang Y.G., Li C.M., Wang Y. Association between IL18-607C/A and -137G/C polymorphisms and susceptibility to non-small cell lung cancer in a Chinese population. Genet Mol Res. 2016; 15 (4). doi:10.4238/gmr15048822.; Zhao K., Xu J., Tian H. Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis. Genet Mol Res. 2016; 15 (1): 15017021. doi:10.4238/gmr.15017021.; Quesada B.J.R., Talpaz M., Rios A., Kurzrock R., Gutterman J.U. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol. 2015; 4 (20): 234–243. doi:10.1200/JCO.1986.4.2.234; Von Ah.D.M., Kang D.H., Carpenter J.S. Predictors of cancerrelated fatigue in women with breast cancer before, during, and after adjuvant therapy. Cancer Nurs. 2008; 31 (2): 134–44. doi:10.1097/01. NCC.0000305704.84164.54.; Xu J., Yin Z., Cao S., Gao W., Liu L., Yin Y., Liu P., Shu Y. Systematic review and meta-analysis on the association between IL-1B polymorphisms and cancer risk. PLoS One. 2013; 8 (5): e63654. doi:10.1371/journal. pone.0063654.; Bastami S., Norling C., Trinks C., Holmlund B., Walz T.M., Ahlner J., Uppugunduri S. Inhibitory effect of opiates on LPS mediated release of TNF and IL-8. Acta Oncol. 2013 Jun; 52 (5): 1022–33. doi:10.3109/0284186X.2012.737932.; Dahl A.A., Nesvold I.L., Reinertsen K.V., Fossa S.D. Arm/shoulder problems and insomnia symptoms in breast cancer survivors: crosssectional, controlled and longitudinal observations. Sleep Med. 2011 Jun; 12 (6): 584–90. doi:10.1016/j.sleep.2011.01.011.; McCann B., Miaskowski C., Koetters T., Baggott C., West C., Levine J.D., Elboim C., Abrams G., Hamolsky D., Dunn L., Rugo H., Dodd M., Paul S.M., Neuhaus J., Cooper B., Schmidt B., Langford D., Cataldo J., Aouizerat B.E. Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. J Pain. 2012; 13 (5): 425–37. doi:10.1016/j.jpain.2011.02.358.; Barratt D.T., Klepstad P., Dale O., Kaasa S., Somogyi A.A. Innate Immune Signalling Genetics of Pain, Cognitive Dysfunction andSickness Symptoms in Cancer Pain Patients Treated with Transdermal Fentanyl. PLoS One. 2015 Sep 2; 10 (9): e0137179. doi:10.1371/journal. pone.0137179.; Sakamoto K., Takeda S., Kanekiyo S., Nishiyama M., Kitahara M., Ueno T., Yamamoto S., Yoshino S., Hazama S., Okayama N., Nagano H. Association of tumor necrosis factor-α polymorphism with chemotherapyinduced oral mucositis in patients with esophageal cancer. Mol Clin Oncol. 2017 Jan; 6 (1): 125–129. doi:10.3892/mco.2016.1081.; Liu X., Wang Z., Yu J., Lei G., Wang S. Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2010 Dec; 124 (3): 821–5. doi:10.1007/s10549-010- 0910-3.; Ransohoff R.M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity. 2009 Nov 20; 31 (5): 711–21. doi:10.1016/j.immuni.2009.09.010.; Nedoszytko B., Olszewska B., Roszkiewicz J., Glen J., Zabłotna M., Ługowska-Umer H., Nowicki R., Sokołowska-Wojdyło M. The role of polymorphism of interleukin-2, -10, -13 and TNF-α genes in cutaneous T-cell lymphoma pathogenesis. Postepy Dermatol Alergol. 2016 Dec; 33 (6): 429–434. doi:10.5114/ada.2016.63881.; Li Y., Ou C., Shu H., Zhao H., Zhu B. The ERCC1-4533/8092, TNF-α 238/308 polymorphisms and the risk of hepatocellular carcinoma in Guangxi Zhuang populations of China: Case-control study. Medicine (Baltimore). 2016; 95 (44): e5217. doi:10.1097/md.0000000000005217.; Gutiérrez-Hurtado I.A., Puebla-Pérez A.M., Delgado-Saucedo J.I., Figuera L.E., Zúñiga-González G.M., Gomez-Mariscal K., Ronquillo-Carreón C.A., Gallegos-Arreola M.P. Association between TNF-α-308G>A and -238G>A gene polymorphisms and TNF-α serum levels in Mexican colorectal cancer patients. Genet Mol Res. 2016; 15 (2). doi:10.4238/gmr.15028199.; Luo Y., Ye Z., Li K., Chen R., Li S., Pang J. Associations between polymorphisms in the IL-4 and IL-4 receptor genes and urinary carcinomas: a meta-analysis. Int J Clin Exp Med. 2015; 8 (1): 1227–1233.; Burada F., Dumitrescu T., Nicoli R., Ciurea M.E., Angelescu C., Mixich F., Ioana M. IL-1RN +2018T>C polymorphismis correlated with colorectal cancer. Mol Biol Rep. 2013; 40 (4): 2851–7. doi:10.1007/ s11033-012-2300-x.; Sáenz López P., Vázquez Alonso F., Romero J.M., Carretero R., Tallada Buñuel M., Ruiz Cabello F., Cózar Olmo J.M. Polymorphisms in inflammatory response genes in metastatic renal cancer. Actas Urol Esp. 2009; 33 (5): 474–81.; Bapat A.A., Hostetter G., VonHoff D.D., Han H. Perineural invasion and associated pain in pancreatic cancer. Nat Rev Cancer. 2011; 11 (10): 695–707.doi:10.1038/nrc3131.; Reyes-Gibby C.C., Wang J., Spitz M., Wu X., Yennurajalingam S., Shete S. Genetic variations in Interleukin-8 and Interleukin-10 are associated with pain, depressed mood, and fatigue in lung cancer patients. J Pain Symptom Manage. 2013; 46 (2): 161–72. doi:10.1016/j. jpainsymman.2012.07.019.; Ando K., Takahashi F., Motojima S., Nakashima K., Kaneko N., Hoshi K., Takahashi K. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol. 2013; 31 (60): e69–e72. doi:10.1200/JCO.2012.44.2020.; https://www.siboncoj.ru/jour/article/view/617

Διαθεσιμότητα: https://www.siboncoj.ru/jour/article/view/617
https://doi.org/10.21294/1814-4861-2017-16-5-87-94

GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS ; Общие принципы лечения скелетно-мышечной боли: междисциплинарный консенсус

Συγγραφείς: E. L. Nasonov, N. N. Yakhno, A. E. Karateev, L. I. Alekseeva, A. N. Barinov, A. E. Barulin, O. S. Davydov, A. B. Danilov, M. V. Zhuravleva, B. V. Zavodovsky, S. S. Kopenkin, M. L. Kukishkin, V. A. Parfenov, M. A. Strakhov, V. P. Tyurin, N. V. Chichasova, S. A. Chorbinskaya, Е. Л. Насонов, Н. Н. Яхно, А. Е. Каратеев, Л. И. Алексеева, А. Н. Баринов, А. Е. Барулин, О. С. Давыдов, А. Б. Данилов, М. В. Журавлева, Б. В. Заводовский, С. С. Копенкин, М. Л. Кукушкин, В. А. Парфенов, М. А. Страхов, В. П. Тюрин, Н. В. Чичасова, С. А. Чорбинская

Πηγή: Rheumatology Science and Practice; Vol 54, No 3 (2016); 247-265 ; Научно-практическая ревматология; Vol 54, No 3 (2016); 247-265 ; 1995-4492 ; 1995-4484 ; 10.14412/rsp20163

Θεματικοί όροι: междисциплинарный консенсус, osteoarthritis, nonspecific back pain, analgesic therapy, interdisciplinary consensus, остеоартроз, неспецифическая боль в спине, анальгетическая терапия

Περιγραφή αρχείου: application/pdf

Relation: https://rsp.mediar-press.net/rsp/article/view/2206/1423; Яхно НН, Кукушкин МЛ, редакторы. Боль (практическое руководство для врачей). Москва: Издательство РАМН; 2012. 512 c. [Yakhno NN, Kukushkin ML, editors. Bol’ (prakticheskoe rukovodstvo dlya vrachei) [Pain (a practical guide for doctors)]. Moscow: Publishing of Russian Academy of Medical Sciences; 2012. 512 p.].; Яхно НН, Кукушкин МЛ. Хроническая боль: медико-биологические и социально-экономические аспекты. Вестник РАМН. 2012;(9):54-8 [Yakhno NN, Kukushkin ML. Chronic pain: medical-biological and socio-economic aspects. Vestnik RAMN. 2012;(9):54-8 (In Russ.)].; Яхно НН, Баринов АН, Подчуфарова ЕВ. Невропатическая и скелетно-мышечная боль. Современные подходы к диагностике и лечению. Клиническая медицина. 2008;(11):9-15 [Yakhno NN, Barinov AN, Podchufarova EV. Neuropathic and musculoskeletal pain. Current approaches to diagnosis and treatment. Klinicheskaya Meditsina. 2008;(11):9-15 (In Russ.)].; Насонов ЕЛ, Насонова ВА. Фармакотерапия боли: взгляд ревматолога. Consilium medicum. 2000;2(12):7-14 [Nasonov EL, Nasonova VA. Pharmacotherapy of pain: a view of the rheumatologist. Consilium medicum. 2000; 2 (12): 7-14 (In Russ.)].; Кукушкин МЛ, Хитров НК. Общая патология боли. Москва: Медицина; 2004. 144 с. [Kukushkin ML, Khitrov NK. Obshchaya patologiya boli [General pathology of pain]. Moscow: Medicine; 2004. 144 p.].; Голубев ВЛ. Боль – междисциплинарная проблема. Русский медицинский журнал. 2008;16 (Спец. выпуск):3-7 [Golubev VL. The pain – an interdisciplinary problem. Russkii Meditsinskii Zhurnal. 2008;16 (Special Issue):3-7 (In Russ.)].; Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163-96. doi:10.1016/S0140-6736(12)61729-2; Harker J, Reid K, Bekkering G, et al. Epidemiology of chronic pain in Denmark and Sweden. Pain Res Treat. 2012;2012:371248. doi:10.1155/2012/371248; Woolf A, Pfleger B. Burden of major musculoskeletal conditions. Bull WHO. 2003;81:646-56.; Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10(4):287-333. doi:10.1016/j.ejpain.2005.06.009; Эрдес ШФ, Дубинина ТВ, Галушко ЕА. Боли в нижней части спины в общеклинической практике. Терапевтический архив. 2008;80(5):59-61 [Erdes ShF, Dubinina TV, Galushko EA. Pain in the lower back in the general clinical practice. Terapevticheskii Arkhiv. 2008;80(5):59-61 (In Russ.)].; Friedly J, Standaert C, Chan L. Epidemiology of spine care: the back pain dilemma. Phys Med Rehabil Clin N Am. 2010;21(4):659-77. doi:10.1016/j.pmr.2010.08.002; Juniper M, Le T, Mladsi D. The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review. Expert Opin Pharmacother. 2009;10(16):2581-92. doi:10.1517/14656560903304063; Litwic A, Edwards M, Dennison E, Cooper C. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185-99. doi:10.1093/bmb/lds038; Zhang Y, Jordan J. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355-69. doi:10.1016/j.cger.2010.03.001; Murphy L, Helmick C. The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs. 2012;112(3 Suppl 1):13-9. doi:10.1097/01.NAJ.0000412646.80054.21; Millar NL, Murrell GA, McInnes IB. Alarmins in tendinopathy: unravelling new mechanisms in a common disease. Rheumatology (Oxford). 2013 May;52(5):769-79. doi:10.1093/rheumatology/kes409. Epub 2013 Jan 28.; Scott A, Ashe MC. Common tendinopathies in the upper and lower extremities. Curr Sports Med Rep. 2006 Sep;5(5):233-41. doi:10.1097/01.CSMR.0000306421.85919.9c; Van Tulder M, Malmivaara A, Koes B. Repetitive strain injury. Lancet. 2007;369(9575):1815-22. doi:10.1016/S0140-6736(07)60820-4; Кукушкин МЛ, Табеева ГР, Подчуфарова ЕВ. Болевой синдром: патофизиология, клиника, лечение. Москва: ИМА-ПРЕСС; 2011. 72 с. [Kukushkin ML, Tabeeva GR, Podchufarova EV. Bolevoi sindrom: patofiziologiya, klinika, lechenie [Pain syndrome: pathophysiology, clinical features, treatment]. Moscow: IMA-PRESS; 2011. 72 p.].; Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011 Dec;13(6):513-20. doi:10.1007/s11926-011-0206-6; Edmonds S. Therapeutic targets for osteoarthritis. Maturitas. 2009 Jul 20;63(3):191-4. doi:10.1016/j.maturitas.2009.03.015. Epub 2009 May 6.; Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005 Sep;17(5):624-8. doi:10.1097/01.bor.0000172800.49120.97; Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013 Jun 1;87(11):766-72.; Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009 May-Jun;31(3):206-19. doi:10.1016/j.genhosppsych. 2008.12.006. Epub 2009 Mar 4.; Насонова ВА, Фоломеева ОМ, Эрдес ШФ. Ревматические заболевания в Российской Федерации в начале XXI века глазами статистики. Терапевтический архив. 2009;(6):5-10 [Nasonova VA, Folomeeva OM, Erdes ShF. Rheumatic diseases in the Russian Federation at the beginning of the XXI century through the eyes of statistics. Terapevticheskii Arkhiv. 2009;(6):5-10 (In Russ.)].; Балабанова РМ, Эрдес ШФ. Распространенность ревматических заболеваний в России в 2012-2013 гг. Научно-практическая ревматология. 2015;52(2):120-4 [Balabanova RM, Erdes ShF. The incidence and prevalence of rheumatic diseases in Russia in 2012–2013. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(2):120-4 (In Russ.)]. doi:10.14412/1995-4484-2015-120-124; Каратеев АЕ. Болезни костно-мышечной системы в практике 2102 врачей разных специальностей: структура патологии и мнение специалистов об эффективности НПВП (предварительные данные эпидемиологического исследования КОРОНА-2). Consilium medicum, 2013;15(9):95-100 [Karateev AE. Diseases of the musculoskeletal system in practice in 2102 doctors of different specialties: pathology structure and experts' opinion on the effectiveness of non-steroidal anti-inflammatory drugs (preliminary data of CROWN-2 epidemiological studies). Consilium medicum. 2013;15(9):95-100. (In Russ.)].; McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363-88. doi:10.1016/j.joca.2014.01.003. Epub 2014 Jan 24.; Bruyere O, Cooper C, Pelletier J-P, et al. An algorithm recommendation for the management of knee Osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014;44:253-63. doi:10.1016/j.semarthrit.2014.05.014; Koes BW, van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010 Dec;19(12):2075-94. doi:10.1007/s00586-010-1502-y; Van Hecke O, Torrance N, Smith B. Chronic pain epidemiology and its clinical relevance. Br J Anaesth. 2013;111(1):13-8. doi:10.1093/bja/aet123; Smith B, Elliott A, Hannaford P, Chambers W. Factors related to the onset and persistence of chronic back pain in the community: results from a general population follow-up study. Spine. 2004;29(9):1032-40. doi:10.1097/00007632-200405010-00016; Bergman S, Herrstrom P, Jacobsson L, Petersson I. Chronic widespread pain: a three year follow-up of pain distribution and risk factors. J Rheumatol. 2002;29:818-25.; Andersen JC. Is immediate imaging important in managing low back pain? J Athl Train. 2011 Jan-Feb;46(1):99-102. doi:10.4085/1062-6050-46.1.99; Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for lowback pain: systematic review and meta-analysis. Lancet. 2009 Feb 7;373(9662):463-72. doi:10.1016/S0140-6736(09)60172-0; Jarvik J, Gold L, Comstock B, et al. Association of early imaging for back pain with clinical outcomes in older adults. JAMA. 2015;313(11):1143-53. doi:10.1001/jama.2015.1871; Igarashi A, Kikuchi S, Konno S, Olmarker K. Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine (Phila Pa 1976). 2004 Oct 1;29(19):2091-5. doi:10.1097/01.brs.0000141265.55411.30; Genevay S, Finckh A, Payer M, et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine (Phila Pa 1976). 2008 Sep 1;33(19):2041-6. doi:10.1097/BRS.0b013e318183bb86; Cuellar JM, Golish SR, Reuter MW, et al. Cytokine evaluation in individuals with low back pain using discographic lavage. Spine J. 2010 Mar;10(3):212-8. doi:10.1016/j.spinee.2009.12.007; Schaible H. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep. 2012;14(6):549-56. doi:10.1007/s11926-012-0279-x; Walsh D, Bonnet C, Turner E, et al. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage. 2007 Jul;15(7):743-51. Epub 2007 Mar 21. doi:10.1016/j.joca.2007.01.020; Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001 Jun;44(6):1237-47. doi:10.1002/1529-0131(200106)44:63.0.CO;2-F; Alvarez-Soria MA, Largo R, Santillana J, et al. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis. 2006 Aug;65(8):998-1005. Epub 2006 Feb 13. doi:10.1136/ard.2005.046920; McCarberg BH, Ruoff GE, Tenzer-Iglesias P, Weil AJ. Diagnosis and treatment of low-back pain because of paraspinous muscle spasm: a physician roundtable. Pain Med. 2011 Nov;12 Suppl 4:S119-27. doi:10.1111/j.1526-4637.2011.01253.x; Lund JP, Donga R, Widmer CG, Stohler CS. The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol. 1991;69:683-94. doi:10.1139/y91-102; Roland M. A critical review of the evidence for pain-spasm-pain cycle in spinal disorders. Clin Biomech. 1986;1:102-9. doi:10.1016/0268-0033(86)90085-9; Iglesias-Gonzalez JJ, Munoz-Garcia MT, Rodrigues-de-Souza DP, et al. Myofascial trigger points, pain, disability, and sleep quality in patients with chronic nonspecific low back pain. Pain Med. 2013 Dec;14(12):1964-70. doi:10.1111/pme.12224. Epub 2013 Aug 15.; Ramsook RR, Malanga GA. Myofascial low back pain. Curr Pain Headache Rep. 2012 Oct;16(5):423-32. doi:10.1007/s11916-012-0290-y; Fisher NM, Pendergast DR. Reduced muscle function in patients with osteoarthritis. Scand J Rehabil Med. 1997 Dec;29(4):213-21.; Arokoski MH, Arokoski JP, Haara M, et al. Hip muscle strength and muscle cross sectional area in men with and without hip osteoarthritis. J Rheumatol. 2002 Oct;29(10):2185-95.; Blume C, Wang SS. Comparison of changes in supraspinatus muscle thickness in persons with subacromial impingement syndrome and asymptomatic adults. Physiother Theory Pract. 2014 Nov;30(8):544-51. doi:10.3109/09593985.2014.902522. Epub 2014 Mar 28.; Silldorff MD, Choo AD, Choi AJ, et al. Effect of supraspinatus tendon injury on supraspinatus and infraspinatus muscle passive tension and associated biochemistry. J Bone Joint Surg Am. 2014 Oct 15;96(20):e175. doi:10.2106/JBJS.M.01315; Thomopoulos S, Parks WC, Rifkin DB, Derwin KA. Mechanisms of tendon injury and repair. J Orthop Res. 2015 Jan 29. doi:10.1002/jor.22806 [Epub ahead of print].; Millar NL, Hueber AJ, Reilly JH, et al. Inflammation is present in early human tendinopathy. Am J Sports Med. 2010;38(10):2085-91. doi:10.1177/0363546510372613. Epub 2010 Jul 1.; McGonagle D, Benjamin M. Entheses, entehesitis and enthesopathy. Report of rheumatic diseases, series 6, autumn 2009, №4. Available from: www.arc.org.uk/arthinfo/rdr.asp; Gotoh M, Hamada K, Yamakawa H, et al. Interleukin-1-induced glenohumeral synovitis and shoulder pain in rotator cuff diseases. J Orthop Res. 2002 Nov;20(6):1365-71. doi:10.1016/S0736-0266(02)00063-3; Voloshin I, Gelinas J, Maloney MD, et al. Proinflammatory cytokines and metalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy. 2005 Sep;21(9):1076.e1-1076.e9. doi:10.1016/j.arthro.2005.05.017; Benjamin M, McGonagle D. Histopathologic changes at «synovio-entheseal complexes» suggesting a novel mechanism for synovitis in osteoarthritis and spondylarthritis. Arthritis Rheum. 2007;56 (11):3601-9. doi:10.1002/art.23078; Haviv B, Bronak S, Thein R. The complexity of pain around the knee in patients with osteoarthritis. Isr Med Assoc J. 2013 Apr;15(4):178-81.; Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013 Jan;21(1):10-5. doi:10.1016/j.joca.2012.09.012. Epub 2012 Oct 4.; Tsao H, Tucker KJ, Coppieters MW, Hodges PW. Experimentally induced low back pain from hypertonic saline injections into lumbar interspinous ligament and erector spinae muscle. Pain. 2010 Jul;150(1):167-72. doi:10.1016/j.pain.2010.04.023. Epub 2010 May 26.; Panjabi MM. A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction. Eur Spine J. 2006 May;15(5):668-76. doi:10.1007/s00586-005-0925-3. Epub 2005 Jul 27.; Longo UG, Berton A, Khan WS, et al. Histopathology of rotator cuff tears. Sports Med Arthrosc. 2011 Sep;19(3):227-36. doi:10.1097/JSA.0b013e318213bccb; Ko JY, Wang FS. Rotator cuff lesions with shoulder stiffness: updated pathomechanisms and management. Chang Gung Med J. 2011 Jul-Aug;34(4):331-40.; Raastad J, Reiman M, Coeytaux R, et al. The association between lumbar spine radiographic features and low back pain: A systematic review and meta-analysis. Semin Arthritis Rheum. 2015 Apr;44(5):571-85. doi:10.1016/j.semarthrit.2014.10.006. Epub 2014 Dec 8.; De Schepper EI, Damen J, van Meurs JB, et al. The association between lumbar disc degeneration and low back pain: the influence of age, gender, and individual radiographic features. Spine (Phila Pa 1976). 2010 Mar 1;35(5):531-6. doi:10.1097/BRS.0b013e3181aa5b33; Scheele J, de Schepper EI, van Meurs JB, et al. Association between spinal morning stiffness and lumbar disc degeneration: the Rotterdam Study. Osteoarthritis Cartilage. 2012 Sep;20(9):982-7. doi:10.1016/j.joca.2012.05.011. Epub 2012 Jun 12.; Beresford ZM, Kendall RW, Willick SE. Lumbar facet syndromes. Curr Sports Med Rep. 2010 Jan-Feb;9(1):50-6. doi:10.1249/JSR.0b013e3181caba05; Cohen SP, Raja SN. Pathogenesis, diagnosis, and treatment of lumbar zygapophysial (facet) joint pain. Anesthesiology. 2007 Mar;106(3):591-614. doi:10.1097/00000542-200703000-00024; Туровская ЕФ, Алексеева ЛИ, Филатова ЕГ. Современные представления о патогенетических механизмах боли при остеоартрозе. Научно-практическая ревматология. 2014;52(4):438-44 [Turovskaya EF, Alekseeva LI, Filatova EG. Current ideas about the pathogenetic mechanisms of pain in osteoarthrosis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):438-44 (In Russ.)]. doi:10.14412/1995-4484-2014-438-444; Mease P, Hanna S, Frakes E, Altman R. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol. 2011;38(8):1546-51. doi:10.3899/jrheum.100759; Hochman J, French M, Bermingham S, Hawker G. The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken). 2010;62(7):1019-23. doi:10.1002/acr.20142; Fishbain DA, Cole B, Lewis JE, Gao J. What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review. Pain Med. 2014 Jan;15(1):4-15. doi:10.1111/pme.12229. Epub 2013 Oct 4.; Coombes BK, Bisset L, Vicenzino B. Thermal hyperalgesia distinguishes those with severe pain and disability in unilateral lateral epicondylalgia. Clin J Pain. 2012;28:595-601. doi:10.1097/AJP.0b013e31823dd333; Данилов АБ, Давыдов ОС. Нейропатическая боль. Москва: Боргес; 2007. С. 11, 37-45 [Danilov AB, Davydov OS. Neiropaticheskaya bol’ [Neuropathic pain]. Moscow: Borges; 2007. P. 11, 37-45].; Englbrecht M, Tarner I, van der Heijde D, et al. Measuring pain and efficacy of pain treatment in inflammatory arthritis: A systematic literature review. J Rheumatol Suppl. 2012;90:3-10. doi:10.3899/jrheum.120335; Whittle S, Colebatch A, Buchbinder R, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: Integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology. 2012;51(8):1416-25. doi:10.1093/rheumatology/kes032; Ostelo R, de Vet H. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol. 2005;19(4):593-607. doi:10.1016/j.berh.2005.03.003; Stauffer M, Taylor S, Watson D, et al. Definition of nonresponse to analgesic treatment of arthritic pain: An analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale. Int J Inflam. 2011;2011:231926. doi:10.4061/2011/231926; Angst F, Aeschlimann A, Stucki G. Smallest detectable and minimal clinically important differences of rehabilitation intervention with their implications for required sample sizes using WOMAC and SF-36 quality of life measurement instruments in patients with osteoarthritis of the lower extremities. Arthritis Rheum. 2001;45(4):384-91. doi:10.1002/1529-0131(200108)45:43.0.CO;2-0; Cepeda M, Africano J, Polo R, et al. What decline in pain intensity is meaningful to patients with acute pain? Pain. 2003;105(1-2):151-7. doi:10.1016/S0304-3959(03)00176-3; Каратеев АЕ. Факторы, влияющие на эффективность обезболивающей терапии. Эффективная фармакотерапия. Неврология и Психиатрия. 2013;47(5):46-53 [Karateev AE. Factors affecting the effectiveness of pain therapy. Effektivnaya farmakoterapiya. Nevrologiya i Psikhiatriya. 2013;47(5):46-53 (In Russ.)].; Farrar J, Young J, La Moreaux L, et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149-58. doi:10.1016/S0304-3959(01)00349-9; Salaffi F, Stancati A, Silvestri C, et al. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283-91. doi:10.1016/j.ejpain.2003.09.004; Kovacs F, Abraira V, Royuela A, et al. Minimum detectable and minimal clinically important changes for pain in patients with nonspecific neck pain. BMC Musculoskelet Disord. 2008;9:43. doi:10.1186/1471-2474-9-43; Каратеев АЕ, Насонов ЕЛ, Яхно НН и др. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современная ревматология. 2015;9(1):4-24 [Karateev AE, Nasonov EL, Yakhno NN, et al. Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice». Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2015;9(1):4-23. (In Russ.)]. doi:10.14412/1996-7012-2015-1-4-23; Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015 Feb 20;8:105-18. doi:10.2147/JPR.S75160. eCollection 2015.; Daniels S, Bandy D, Christensen S, et al. Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model. Clin J Pain. 2011;27(1):1-8. doi:10.1097/AJP.0b013e3181ed0639; Brattwall M, Turan I, Jakobsson J. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol. Anesth Analg. 2010;111(2):544-9. doi:10.1213/ANE.0b013e3181e3d87c; O'Donnell J, Ekman E, Spalding W, et al. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flareup of chronic low-back pain: results from two randomized, double-blind, 6-week studies. J Int Med Res. 2009;37(6):1789-802. doi:10.1177/147323000903700615; DeLemos B, Xiang J, Benson C, et al. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther. 2011;18(3):216-26. doi:10.1097/MJT.0b013e3181cec307; Innes G, Croskerry P, Worthington J, et al. Ketorolac versus acetaminophen-codeine in the emergency department treatment of acute low back pain. J Emerg Med. 1998 Jul-A Aug;16(4):549-56. doi:10.1016/S0736-4679(98)00044-4; Beaulieu A, Peloso P, Haraoui B, et al. Once-daily, controlledrelease tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial. Pain Res Manag. 2008;13(2):103-10. doi:10.1155/2008/903784; Bjordal J, Klovning A, Ljunggren A, Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain. 2007 Feb;11(2):125-38. Epub 2006 May 8. doi:10.1016/j.ejpain.2006.02.013; Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000396. doi:10.1002/14651858.CD000396.pub3; Boudreault J, Desmeules F, Roy J, et al. The efficacy of oral nonsteroidal anti-inflammatory drugs for rotator cuff tendinopathy: a systematic review and meta-analysis. J Rehabil Med. 2014 Apr;46(4):294-306. doi:10.2340/16501977-1800; Moore R, Derry S, McQuay H. Discontinuation rates in clinical trials in musculoskeletal pain: meta-analysis from etoricoxib clinical trial reports. Arthritis Res Ther. 2008;10(3):R53. doi:10.1186/ar2422; Furst D, Kolba K, Fleischmann R, et al. Dose response and safety study of meloxicam up to 22.5 mg daily in rheumatoid arthritis: a 12 week multicenter, double blind, dose response study versus placebo and diclofenac. J Rheumatol. 2002;29(3):436-46.; Derry S, Moore RA. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev. 2013 Oct 22;10:CD004233. doi:10.1002/14651858. CD004233.pub4.; Yakhno N, Guekht A, Skoromets A, et al. Analgesic efficacy and safety of lornoxicam quick-release formulation compared with diclofenac potassium. Clin Drug Invest. 2006;26(5):267-77. doi:10.2165/00044011-200626050-00004; Dougados M, Le Henanff A, Logeart I, Ravaud P. Short-term efficacy of rofecoxib and diclofenac in acute shoulder pain: a placebo-controlled randomized trial. PLoS Clin Trials. 2007 Mar 9;2(3):e9. doi:10.1371/journal.pctr.0020009; Chandanwale AS, Sundar S, Latchoumibady K, et al. Efficacy and safety profile of combination of tramadol-diclofenac versus tramadol-paracetamol in patients with acute musculoskeletal conditions, postoperative pain, and acute flare of osteoarthritis and rheumatoid arthritis: a Phase III, 5-day open-label study. J Pain Res. 2014 Aug 12;7:455-63. doi:10.2147/JPR.S67817. eCollection 2014.; Tramer MR, Williams JE, Carroll D, et al. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol Scand. 1998 Jan;42(1):71-9. doi:10.1111/j.1399-6576.1998.tb05083.x; Altman R, Barthel H. Topical therapies for osteoarthritis. Drugs. 2011;71(10):1259-79. doi:10.2165/11592550-000000000-00000; Derry S, Moore R, Rabbie R. Topical NSAIDs for chronic muscoloskeletal pain in adults. Cochrane Database Sys Rev. 2012 Sep 12;9:CD 007400.; Baraf H, Gloth F, Barthel H, et al. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, doubleblind, parallel-group, placebo-controlled, multicentre trials. Drugs Aging. 2011;28(1):27-40. doi:10.2165/11584880-000000000-00000; Goldstein JL, Cryer B. Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug Healthc Patient Saf. 2015 Jan 22;7:31-41. doi:10.2147/DHPS.S71976. eCollection 2015.; Harirforoosh S, Asghar W, Jamali F. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821-47. doi:10.18433/J3VW2F; Moore A, Makinson G, Li C. Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials. Arthritis Res Ther. 2013 Jan 8;15(1):R6. doi:10.1186/ar4134; Day R, Graham G, Whelton A. The position of paracetamol in the world of analgesics. Am J Therap. 2000;7:51-5. doi:10.1097/00045391-200007020-00002; Prescott L. Paracetamol: past, present and future. Am J Ther. 2000;7:135-43. doi:10.1097/00045391-200007020-00011 113. Towheed T, Maxwell L, Judd M, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006;25(1):CD004257. doi:10.1002/14651858.cd004257.pub2; Machado G, Maher C, Ferreira P, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. Brit Med J. 2015 Mar 31;350:h1225. doi:10.1136/bmj.h1225; Garcia Rodriguez L, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology. 2001;12(5):570-6. doi:10.1097/00001648-200109000-00018; Chan A, Manson J, Albert C, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation. 2006;113(12):1578-87. doi:10.1161/CIRCULATIONAHA.105.595793; Dedier J, Stampfer M, Hankinson S, et al. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002;40(5):604-8. doi:10.1161/01.HYP.0000035856.77718.DA; Forman J, Rimm E, Curhan G. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med. 2007;167(4):394-9. doi:10.1001/archinte.167.4.394; Ong C, Seymour R, Lirk P, Merry A. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010,110(4):1170-9. doi:10.1213/ane.0b013e3181cf9281; McQuay H, Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl. 2003;28:19-22.; Bronstein A, Spyker D, Cantilena L, et al. 2006 Annual Report of the American Association of Poison Control Centers National Poison Data System (NPDS). Clin Toxicol (Phila). 2007;45:815-917. doi:10.1080/15563650701754763; Chaparro LE, Furlan AD, Deshpande A, et al. Opioids compared with placebo or other treatments for chronic low back pain: an update of the Cochrane Review. Spine (Phila Pa 1976). 2014 Apr 1;39(7):556-63. doi:10.1097/BRS.0000000000000249; Cepeda M, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol. 2007,34(3):543-55.; Da Costa BR, Nü esch E, Kasteler R, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev. 2014 Sep 17;9:CD003115. doi:10.1002/14651858.cd003115.pub4; Metscher B, Kü bler U, Jahnel-Kracht H. Dexketoprofentrometamol and tramadol in acute lumbago. Fortschr Med Orig. 2001;118(4):147-51.; Pavelka K, Peliskova Z, Stehlikova H, et al. Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol. Clin Drug Investig. 1998;16(6):421-9. doi:10.2165/00044011-199816060-00002; Adams E, Breiner S, Cicero T, et al. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J Pain Symptom Manage. 2006;31(5):465-76. doi:10.1016/j.jpainsymman.2005.10.006; Ritvo J, Koonce R, Thurstone C, Causey HL 3rd. Tramadol dependence: treatment with buprenor-phine/naloxone. Am J Addict. 2007;16(1):67-8. doi:10.1080/10550490601080118; Trescot A, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: An update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008;Opioids Special Issue 11:5-62.; Van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003;(2):CD004252. doi:10.1002/14651858.cd004252; Гурак СВ, Парфенов ВА, Борисов КН. Мидокалм в комплексной терапии острой поясничной боли. Боль. 2006;(3):27-30 [Gurak SV, Parfenov VA, Borisov KN. Mydocalm in the treatment of acute low back pain. Bol’. 2006;(3):27-30 (In Russ.)].; Ходинка Л, Меилингер М, Сабо Ж, Залавари И. Лечение острой поясничной боли Мидокалмом. Результаты международного мультицентрового рандомизированного двойного-слепого плацебо-контролируемого клинического исследования. Русский медицинский журнал. 2003;(5):246-9 [Khodinka L, Meilinger M, Sabo Zh, Zalavari I. Treatment of acute low back pain Mydocalm. The results of an international, multicentre, randomized, double-blind, placebo-controlled clinical trial. Russkii Meditsinskii Zhurnal. 2003;(5):246-9 (In Russ.)].; Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain. 1996 Oct;67(2-3):417-25. doi:10.1016/0304-3959(96)03187-9; Кукушкин МЛ. Современный взгляд на механизм действия Мидокалма. Consilium medicum. 2013;15(2):89-94 [Kukushkin ML. Modern view of the mechanism of action Mydocalm. Consilium medicum. 2013;15(2):89-94. (In Russ.)].; Шарапова ЕП, Алексеева ЛИ, Зайцева ЕМ и др. Применение миорелаксантов в комплексной терапии остеоартроза. Consilium medicum. 2008;(2):30-2 [Sharapova EP, Alekseeva LI, Zaitseva EM, et al. The use of muscle relaxants in the treatment of osteoarthritis. Consilium Medicum. 2008;(2):30-2 (In Russ.)].; Berry H, Hutchinson D. A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain. J Int Med Res. 1988;16(2):75-82.; Berry H, Hutchinson D. Tizanidine and ibuprofen in acute lowback pain: results of a double-blind multicentre study in general practice. J Int Med Res. 1988;16(2):83-91.; Sirdalud Ternilin Asia-Pacific Study group. Efficacy and gastroprotective effects of tizanidine plus diclofenac versus placebo plus diclofenac in patients with painful muscle spasm. Curr Ther Res. 1998;59:13-22. doi:10.1016/S0011-393X(98)85019-4; Pareek A, Chandurkar N, Chandanwale A, et al. Aceclofenactizanidine in the treatment of acute low back pain: a doubleblind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone. Eur Spine J. 2009;18(12):1836-42. doi:10.1007/s00586-009-1019-4; Karol D, Muzyk A, Preud'homme X. A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature. Gen Hosp Psychiatry. 2011;33(1):84.; Del Rosario M, Weachter R, Flaker G. Drug-induced QT prolongation and sudden death. Mol Med. 2010;107(1):53-8.; Kaddar N, Vigneault P, Pilote S, et al. Tizanidine (Zanaflex): A muscle relaxant that may prolong the QT interval by blocking IKr. J Cardiovasc Pharmacol Ther. 2012 Mar;17(1):102-9. doi:10.1177/1074248410395020. Epub 2011 Feb 11.; Publow S, Branam D. Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy. Am J Health Syst Pharm. 2010;67(19):1606-10. doi:10.2146/ajhp090657; Devulder J. Flupirtine in pain management: pharmacological properties and clinical use. CNS Drugs. 2010;24(10):867-81. doi:10.2165/11536230-000000000-00000; Klawe C, Maschke M. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound. Expert Opin Pharmacother. 2009;10(9):1495-500. doi:10.1517/14656560902988528; Harish S, Bhuvana K, Bengalorkar GM, Kumar TN. Flupirtine: Clinical pharmacology. J Anaesthesiol Clin Pharmacol. 2012;28:172-7. doi:10.4103/0970-9185.94833; Ueberall M, Mueller-Schwefe G, Terhaag B. Efficacy and tolerability of flupirtine in subacute/chronic musculoskeletal pain – results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials. Int J Clin Pharmacol Ther. 2011;49(11):637-47. doi:10.5414/CP210000; Uberall MA, Mueller-Schwefe GH, Terhaag B. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study. Curr Med Res Opin. 2012 Oct;28(10):1617-34. doi:10.1185/03007995.2012.726216; Данилов АБ, Николаева НС. Эффективность новой формы флупиртина® (Катадолона форте) в лечении острой боли в спине. Manage pain. 2013;(1):44-8 [Danilov AB, Nikolaeva NS. The effectiveness of a new form of flupirtina® (Katadolona fort) in the treatment of acute pain in the back. Manage Pain. 2013;(1):44-8 (In Russ.)].; Richards B, Whittle S, van der Heijde D, Buchbinder R. Efficacy and safety of neuromodulators in inflammatory arthritis: A Cochrane Systematic Review. J Rheumatol Suppl. 2012;90:28-33. doi:10.3899/jrheum.120339; Chappell A, Ossanna M, Liu-Seifert H, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial. Pain. 2009;146(3):253-60. doi:10.1016/j.pain.2009.06.024; Williamson O, Schroer M, Ruff D, et al. Onset of response with duloxetine treatment in patients with osteoarthritis knee pain and chronic low back pain: a post hoc analysis of placebo-controlled trials. Clin Ther. 2014 Apr 1;36(4):544-51. doi:10.1016/j.clinthera.2014.02.009. Epub 2014 Mar 17.; Pergolizzi JV Jr, Raffa RB, Taylor R Jr, et al. A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain. Pain Pract. 2013 Mar;13(3):239-52. doi:10.1111/j.1533-2500.2012.00578.x. Epub 2012 Jun 21.; Giladi H, Choiniere M, Fitzcharles MA, et al. Pregabalin for chronic pain: does one medication fit all? Curr Med Res Opin. 2015 Jul;31(7):1403-11. doi:10.1185/03007995.2015.1040750. Epub 2015 May 11.; Sakai Y, Ito K, Hida T, et al. Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration. Eur Spine J. 2015 Jun;24(6):1309-17. doi:10.1007/s00586-015-3812-6. Epub 2015 Feb 15.; Romano CL, Romano D, Lacerenza M. Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review. Pain Res Treat. 2012;2012:154781. doi:10.1155/2012/154781. Epub 2012 Apr 26.; Ohtori S, Inoue G, Orita S, et al. Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis. Yonsei Med J. 2013 Sep;54(5):1253-8. doi:10.3349/ymj.2013.54.5.1253; Carmichael N, Katz J, Clarke H, et al. An intensive perioperative regimen of pregabalin and celecoxib reduces pain and improves physical function scores six weeks after total hip arthroplasty: a prospective randomized controlled trial. Pain Res Manag. 2013 May-Jun;18(3):127-32. doi:10.1155/2013/258714; Hameed F, Ihm J. Injectable medications for osteoarthritis. PM&R. 2012;4(5 Suppl):75-81. doi:10.1016/j.pmrj.2012.02.010; Habib G, Saliba W, Nashashibi M. Local effects of intra-articular corticosteroids. Clin Rheumatol. 2010;29(4):347-56. doi:10.1007/s10067-009-1357-y; Dean BJF, Lostis E, Oakley T, et al. Risks and benefits of glucocorticoid treatment for tendinopathy: A systematic review of the effects of local glucocorticoid on tendon. Semin Arthritis Rheum. 2014;43(4):570-6. doi:10.1016/j.semarthrit.2013.08.006; Tallia A, Cardone D. Diagnostic and therapeutic injection of the shoulder region. Am Fam Physician. 2003;67(6):1271-8.; Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010 Nov 20;376(9754):1751-67. doi:10.1016/S0140-6736(10)61160-9. Epub 2010 Oct 21.; Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005328. doi:10.1002/14651858.cd005328.pub2; Насонов ЕЛ, редактор. Ревматология. Клинические рекомендации. Москва: ГЭОТАР-Медиа; 2010. 752 с. [Nasonov EL, editor. Revmatologiya. Klinicheskie rekomendatsii [Rheumatology. Clinical recommendations]. Moscow: GEOTAR-Media; 2010. 752 p.].; Peloso P, Gross A, Haines T, et al. Medicinal and injection therapies for mechanical neck disorders. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000319. doi:10.1002/14651858.cd000319.pub4; Staal JB, de Bie RA, de Vet HC, et al. Injection therapy for subacute and chronic low back pain: an updated Cochrane review. Spine (Phila Pa 1976). 2009 Jan 1;34(1):49-59. doi:10.1097/BRS.0b013e3181909558; Chou R, Hashimoto R, Friedly J, et al. Pain Management Injection Therapies for Low Back Pain [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Mar. AHRQ Technology Assessments.; Farooq M, Devitt A. Perceived efficacy and risks of infection following intra-articular injections: a survey of orthopaedic surgeons. Ir J Med Sci. 2005;174(1):26-32. doi:10.1007/BF03168515; Charalambous C, Tryfonidis M, Sadiq S, et al. Septic arthritis following intraarticular glucocorticoid injection of the knee – a survey of current practice regarding antiseptic technique used during intra-articular glucocorticoid injection of the knee. Clin Rheumatol. 2003;22:386-90. doi:10.1007/s10067-003-0757-7; Younes M, Neffati F, Touzi M, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and nondiabetic patients. Joint Bone Spine. 2007 Oct;74(5):472-6. Epub 2007 Jul 6. doi:10.1016/j.jbspin.2006.10.009; Moon HJ, Choi KH, Lee SI, et al. Changes in blood glucose and cortisol levels after epidural or shoulder intraarticular glucocorticoid injections in diabetic or nondiabetic patients. Am J Phys Med Rehabil. 2014 May;93(5):372-8. doi:10.1097/PHM.0000000000000001; Strand V, McIntyre LF, Beach WR, et al. Safety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trials. J Pain Res. 2015 May 7;8:217-28. doi:10.2147/JPR.S83076. eCollection 2015.; Campbell KA, Erickson BJ, Saltzman BM, et al. Is local viscosupplementation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: A systematic review of overlapping meta-analyses. Arthroscopy. 2015 May 18. pii: S0749-8063(15)00257-1. doi:10.1016/j.arthro.2015.03.030 [Epub ahead of print].; Bannuru RR, Vaysbrot EE, Sullivan MC, McAlindon TE. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014 Apr;43(5):593-9. doi:10.1016/j.semarthrit.2013.10.002. Epub 2013 Oct 14.; Colen S, Haverkamp D, Mulier M, van den Bekerom MP. Hyaluronic acid for the treatment of osteoarthritis in all joints except the knee: what is the current evidence? BioDrugs. 2012 Apr 1;26(2):101-12. doi:10.2165/11630830-000000000-00000; Lieberman JR, Engstrom SM, Solovyova O, et al. Is intra-articular hyaluronic acid effective in treating osteoarthritis of the hip joint? J Arthroplasty. 2015 Mar;30(3):507-11. doi:10.1016/j.arth.2013.10.019. Epub 2013 Nov 8.; Van den Bekerom MP, Lamme B, Sermon A, Mulier M. What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature. Arch Orthop Trauma Surg. 2008 Aug;128(8):815-23. Epub 2007 Sep 15. doi:10.1007/s00402-007-0447-z; Blaine T, Moskowitz R, Udell J, et al. Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am. 2008;90(5):970-9. doi:10.2106/JBJS.F.01116; Chang KV, Hsiao MY, Chen WS, et al. Effectiveness of intra-articular hyaluronic acid for ankle osteoarthritis treatment: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2013 May;94(5):951-60. doi:10.1016/j.apmr.2012.10.030. Epub 2012 Nov 10.; Баринов АН, Пархоменко ЕВ, Махинов КА. Причины отрицательных исходов лечения боли в спине и способы их преодоления. Эффективная фармакотерапия. Неврология. 2014;49(5):40-50 [Barinov AN, Parkhomenko EV, Makhinov KA. The reasons for the negative outcomes of the treatment of back pain and how to overcome them. Effektivnaya farmakoterapiya. Nevrologiya. 2014;49(5):40-50 (In Russ.)].; Алексеева ЛИ. Препараты замедленного действия в лечении остеоартроза. Русский медицинский журнал. 2012;(7):389-94 [Alekseeva LI. Slow-acting drugs in the treatment of osteoarthritis. Russkii Meditsinskii Zhurnal. 2012;(7):389-94 (In Russ.)].; Imagawa K, de Andres M, Hashimoto K, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes – implications for; osteoarthritis. Biochem Biophys Res Commun. 2011;405(3):362-7. doi:10.1016/j.bbrc.2011.01.007; Calamia V, Ruiz-Romero C, Rocha B, et al. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther. 2010;12(4):R138. doi:10.1186/ar3077; Au R, Au A, Rashmir-Raven A, Frondoza C. Inhibition proinflammatory gene expression in chondrocytes, monocytes, and fibroblasts by combination of avocado soybean unsaponiables, glucosamine and chondroitin sulfate. FASEB. 2007;21(6):702-7.; Towheed T, Maxwell L, Anastassiades T, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946. doi:10.1002/14651858.cd002946.pub2; Reichenbach S, Sterchi R, Scherer M, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007;146(8):580-90. doi:10.7326/0003-4819-146-8-200704170-00009; Fidelix TS, Macedo CR, Maxwell LJ, Fernandes Moca Trevisani V. Diacerein for osteoarthritis. Cochrane Database Syst Rev. 2014 Feb 10;2:CD005117. doi:10.1002/14651858.cd005117.pub3; Christensen R, Bartels E, Astrup A, Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2008;16(4):399-408. doi:10.1016/j.joca.2007.10.003; Singh G, Alekseeva L, Alexeev V, Triadafilopoulos G. Glucosamin-chondroitin sulfate reduces pain, disability and NSAID consumption in patients with chronic low back pain: a large, community-based, pilot, open prospective observational study. ELAR, 2013, SAT0419; Каратеев АЕ, Алексеева ЛИ. Оценка переносимости диацереина в реальной клинической практике. Результаты исследования РОКАДА (Ретроспективная Оценка Клинических Аспектов применения Диафлекса при остеоартрозе). Научно-практическая ревматология. 2015;53(2):169-74 [Karateev AE, Alekseeva LI. Estimation of diacerein tolerability in real clinical practice: Results of the RACADA (Retrospective Assessment of Clinical Aspects of using Diaflex in osteoArthritis). Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(2):169-74 (In Russ.)]. doi:10.14412/1995-4484-2015-169-174; Atchison J, Vincent HK. Obesity and low back pain: relationships and treatment. Pain Manag. 2012 Jan;2(1):79-86. doi:10.2217/pmt.11.64; Kotowski S, Davis KG. Influence of weight loss on musculoskeletal pain: Potential short-term relevance. Work. 2010;36(3):295-304. doi:10.3233/WOR-2010-1031; Wai EK, Rodriguez S, Dagenais S, Hall H. Evidence-informed management of chronic low back pain with physical activity, smoking cessation, and weight loss. Spine J. 2008 JanFeb;8(1):195-202. doi:10.1016/j.spinee.2007.10.024; Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2007 Apr;66(4):433-9. doi:10.1136/ard.2006.065904. Epub 2007 Jan 4.; Gudbergsen H, Boesen M, Lohmander LS, et al. Weight loss is effective for symptomatic relief in obese subjects with knee osteoarthritis independently of joint damage severity assessed by high-field MRI and radiography. Osteoarthritis Cartilage. 2012 Jun;20(6):495-502. doi:10.1016/j.joca.2012.02.639. Epub 2012 Mar 5.; Jones A, Silva PG, Silva AC, et al. Impact of cane use on pain, function, general health and energy expenditure during gait in patients with knee osteoarthritis: a randomised controlled trial. Ann Rheum Dis. 2012 Feb;71(2):172-9. doi:10.1136/ard.2010.140178. Epub 2011 Nov 29.; Duivenvoorden T, Brouwer RW, van Raaij TM, et al. Braces and orthoses for treating osteoarthritis of the knee. Cochrane Database Syst Rev. 2015 Mar 16;3:CD004020. doi:10.1002/14651858.cd004020.pub3; Segal NA. Bracing and orthoses: a review of efficacy and mechanical effects for tibiofemoral osteoarthritis. PM&R. 2012 May;4(5 Suppl):S89-96. doi:10.1016/j.pmrj.2012.01.018; Raja K, Dewan N. Efficacy of knee braces and foot orthoses in conservative management of knee osteoarthritis: a systematic review. Am J Phys Med Rehabil. 2011 Mar;90(3):247-62. doi:10.1097/PHM.0b013e318206386b; Bennell KL, Buchbinder R, Hinman RS. Physical therapies in the management of osteoarthritis: current state of the evidence. Curr Opin Rheumatol. 2015 May;27(3):304-11. doi:10.1097/BOR.0000000000000160; Bervoets DC, Luijsterburg PA, Alessie JJ, et al. Massage therapy has short-term benefits for people with common musculoskeletal disorders compared to no treatment: a systematic review. J Physiother. 2015 Jul;61(3):106-16. doi:10.1016/j.jphys.2015.05.018. Epub 2015 Jun 17.; Kadhim-Saleh A, Maganti H, Ghert M, et al. Is low-level laser therapy in relieving neck pain effective? Systematic review and meta-analysis. Rheumatol Int. 2013 Oct;33(10):2493-501. doi:10.1007/s00296-013-2742-z. Epub 2013 Apr 12.; Brosseau L, Robinson V, Wells G, et al. WITHDRAWN: Low level laser therapy (Classes III) for treating osteoarthritis. Cochrane Database Syst Rev. 2007 Jul 18;(1):CD002046.; Pittler MH, Brown EM, Ernst E. Static magnets for reducing pain: systematic review and meta-analysis of randomized trials. CMAJ. 2007 Sep 25;177(7):736-42. doi:10.1503/cmaj.061344; Ryang We S, Koog YH, Jeong KI, Wi H. Effects of pulsed electromagnetic field on knee osteoarthritis: a systematic review. Rheumatology (Oxford). 2013 May;52(5):815-24. doi:10.1093/rheumatology/kes063. Epub 2012 Apr 13.; Li S, Yu B, Zhou D, et al. Electromagnetic fields for treating osteoarthritis. Cochrane Database Syst Rev. 2013 Dec 14;12:CD003523. doi:10.1002/14651858.cd003523.pub2; Menke JM. Do manual therapies help low back pain? A comparative effectiveness meta-analysis. Spine (Phila Pa 1976). 2014 Apr 1;39(7):E463-72. doi:10.1097/BRS.0000000000000230; Rubinstein SM, Terwee CB, Assendelft WJ, et al. Spinal manipulative therapy for acute low-back pain. Cochrane Database Syst Rev. 2012 Sep 12;9:CD008880. doi:10.1002/14651858.cd008880.pub2; Franke H, Franke JD, Fryer G. Osteopathic manipulative treatment for nonspecific low back pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2014 Aug 30;15:286. doi:10.1186/1471-2474-15-286; Lam M, Galvin R, Curry P. Effectiveness of acupuncture for nonspecific chronic low back pain: a systematic review and metaanalysis. Spine (Phila Pa 1976). 2013 Nov 15;38(24):2124-38. doi:10.1097/01.brs.0000435025.65564.b7; Xu M, Yan S, Yin X, et al. Acupuncture for chronic low back pain in long-term follow-up: a meta-analysis of 13 randomized controlled trials. Am J Chin Med. 2013;41(1):1-19. doi:10.1142/S0192415X13500018; Haake M, Mü ller H, Schade-Brittinger C, et al. German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med. 2007;167(17):1892-8. doi:10.1001/Archinte.167.17.1892; Manheimer E, Cheng K, Linde K, et al. Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD001977. doi:10.1002/14651858.CD001977.pub2; Manyanga T, Froese M, Zarychanski R, et al. Pain management with acupuncture in osteoarthritis: a systematic review and metaanalysis. BMC Complement Altern Med. 2014 Aug 23;14:312. doi:10.1186/1472-6882-14-312; So P, Jiang Y, Qin Y. Touch therapies for pain relief in adults. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD006535. doi:10.1002/14651858.cd006535.pub2; Smith K. Against homeopathy – a utilitarian perspective. Bioethics. 2012;26(8):398-409. doi:10.1111/j.1467-8519.2010.01876.x; Brien S, Lachance L, Prescott P, et al. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford). 2011;50(6):1070-82. doi:10.1093/rheumatology/keq234; Beer A, Fey S, Zimmer M, et al. Effectiveness and safety of homeopathic drug combination in the treatment of chronic low back pain. A double-blind, randomized, placebo-controlled clinical trial. MMW Fortschr Med. 2012 Jun 28;154 Suppl 2:48-57.; Long L, Ernst E. Homeopathic remedies for the treatment of osteoarthritis: a systematic review. Br Homeopath J. 2001 Jan;90(1):37-43. doi:10.1054/homp.1999.0449; Koley M, Saha S, Ghosh S. A double-blind, randomized, placebo-controlled feasibility study evaluating individualized homeopathy in managing pain of knee osteoarthritis. J Evid Based Complement Altern Med. 2015 Jul;20(3):186-91. doi:10.1177/2156587214568668; Lembeck M. Quantum physics, medicine and insurance. Versicherungsmedizin. 2007;59(4):179-85.; Jain S, Mills P. Biofield therapies: helpful or full of hype? A best evidence synthesis. Int J Behav Med. 2010;17(1):1-16. doi:10.1007/s12529-009-9062-4; Rosch P. Bioelectromagnetic and subtle energy medicine: the interface between mind and matter. Ann N Y Acad Sci. 2009;1172:297-311. doi:10.1111/j.1749-6632.2009.04535.x; Galle M. Bioresonance, a study of pseudo-scientific language. Forsch Komplementarmed Klass Naturheilkd. 2004;11(5):306.; Hammerschlag R, Marx B, Aickin M. Nontouch biofield therapy: a systematic review of human randomized controlled trials reporting use of only nonphysical contact treatment. J Altern Compliment Med. 2014 Dec;20(12):881-92. doi:10.1089/acm.2014.0017

Διαθεσιμότητα: https://rsp.mediar-press.net/rsp/article/view/2206
https://doi.org/10.14412/1995-4484-2016-247-265

ОБЩИЕ ПРИНЦИПЫ ЛЕЧЕНИЯ СКЕЛЕТНО-МЫШЕЧНОЙ БОЛИ: МЕЖДИСЦИПЛИНАРНЫЙ КОНСЕНСУС

Συγγραφείς: НАСОНОВ Е.Л., ЯХНО Н.Н., КАРАТЕЕВ АНДРЕЙ ЕВГЕНЬЕВИЧ, АЛЕКСЕЕВА Л.И., БАРИНОВ А.Н., БАРУЛИН А.Е., ДАВЫДОВ О.С., ДАНИЛОВ А.Б., ЖУРАВЛЕВА М.В., ЗАВОДОВСКИЙ Б.В., КОПЕНКИН С.С., КУКУШКИН М.Л., ПАРФЕНОВ В.А., СТРАХОВ М.А., ТЮРИН В.П., ЧИЧАСОВА Н.В., ЧОРБИНСКАЯ С.А.

Θεματικοί όροι: СКЕЛЕТНО-МЫШЕЧНАЯ БОЛЬ,ОСТЕОАРТРОЗ,НЕСПЕЦИФИЧЕСКАЯ БОЛЬ В СПИНЕ,АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ,МЕЖДИСЦИПЛИНАРНЫЙ КОНСЕНСУС,MUSCULOSKELETAL PAIN,OSTEOARTHRITIS,NONSPECIFIC BACK PAIN,ANALGESIC THERAPY,INTERDISCIPLINARY CONSENSUS

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/obschie-printsipy-lecheniya-skeletno-myshechnoy-boli-mezhdistsiplinarnyy-konsensus
http://cyberleninka.ru/article_covers/17022533.png

Analgesic treatment, by using a systemic algorithm ; Анальгетическое лечение с использованием системного а л горитма

Συγγραφείς: A. E. Karateev, L. I. Alekseeva, А. Е. Каратеев, Л. И. Алексеева

Πηγή: Modern Rheumatology Journal; Том 9, № 2 (2015); 37-50 ; Современная ревматология; Том 9, № 2 (2015); 37-50 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2015-2

Θεματικοί όροι: osteoarthritis, nonspecific lower back pain, rheumatic disease of juxta-articular soft tissues, central sensitization, analgesic therapy, nonsteroidal anti-inflammatory drugs, paracetamol, tramadol, muscle relaxants, остеоартроз, неспецифическая боль в нижней части спины, ревматическая патология околосуставных мягких тканей, центральная сенситизация, анальгетическая терапия, нестероидные противовоспалительные препараты, парацетамол, трамадол

Περιγραφή αρχείου: application/pdf

Relation: https://mrj.ima-press.net/mrj/article/view/622/607; Яхно НН, Кукушкин МЛ, редакторы. Боль (практическое руководство для врачей). Москва: Издательство РАМН; 2012. 512 c. [Yakhno NN, Kukushkin ML, editors. Bol' (prakticheskoe rukovodstvo dlya vrachei) [Pain (a practical guide for doctors)]. Moscow: Izdatel'stvo RAMN; 2012. 512 p.]; Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2163–96. doi:10.1016/S0140–6736(12)61729–2.; Harker J, Reid KJ, Bekkering GE, et al. Epidemiology of chronic pain in Denmark and Sweden. Pain Res Treat. 2012;2012:371248. doi:10.1155/2012/371248. Epub 2012 May 23.; Gore M, Sadosky A, Stacey BR, et al. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine (Phila Pa 1976). 2012 May 15;37(11):E668–77. doi:10.1097/BRS.0b013e318241e5de.; Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287–333. Epub 2005 Aug 10.; Friedly J, Chan L, Deyo R. Increases in lumbosacral injections in the Medicare population: 1994 to 2001. Spine (Phila Pa 1976). 2007 Jul 15;32(16):1754–60.; Deyo RA, Von Korff M, Duhrkoop D. Opioids for low back pain. BMJ. 2015 Jan 5;350:g6380. doi:10.1136/bmj.g6380.; Deyo R, Mirza S, Turner J, Martin B. Overtreating chronic back pain: time to back off? J Am Board Fam Med. 2009 Jan-Feb;22(1):62–8. doi:10.3122/jabfm.2009.01.080102.; Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA. 2013 Aug 14;310(6):591–608. doi:10.1001/jama.2013.13805.; Насонова ВА, Фоломеева ОМ, Эрдес ШФ. Ревматические заболевания в Российской Федерации в начале XXI века глазами статистики. Терапевтический архив. 2009;(6):5–10. [Nasonova VA, Folomeeva OM, Erdes ShF. Rheumatic diseases in the Russian Federation in the beginning of the XXI century through the eyes of statistics. Terapevticheskii arkhiv. 2009;(6):5–10. (In Russ.)].; Эрдес ШФ, Фоломеева ОМ. Ревматические заболевания и инвалидность взрослого населения Российской Федерации. Научно-практическая ревматология. 2007;(4):4–9. [Erdes ShF, Folomeeva OM. Rheumatic diseases and disability of the adult population of the Russian Federation. Nauchno-prakticheskaya revmatologiya = Rheumatology science and practice. 2007;(4):4–9. (In Russ.)].; Каратеев АЕ. Болезни костно-мышечной системы в практике 2102 врачей разных специальностей: структура патологии и мнение специалистов об эффективности НПВП (предварительные данные эпидемиологического исследования КОРОНА-2). Consilium medicum. 2013;(9):95–100. [Karateev AE. Diseases of the musculoskeletal system in practice of 2102 doctors of different specialties: the structure of pathology and the opinions of experts about the effectiveness of NSAIDs (preliminary data from CORONA-2 epidemiological survey). Consilium medicum. 2013;(9):95–100. (In Russ.)].; Каратеев АЕ, Попкова ТВ, Новикова ДС и др. Оценка риска желудочно-кишечных и сердечно-сосудистых осложнениищ, ассоциированных с приемом нестероидных противовоспалительных препаратов в популяции СНГ: предварительные данные эпидемиологического исследования КОРОНА-2. Научно-практическая ревматология. 2014;52(6):600–6. [Karateev AE, Popkova TV, Novikova DS, et al. Assessment of risk for gastrointestinal and cardiovascular complications associated with the use of nonsteroidal anti-inflammatory drugs in the CIS population: preliminary data of the CORONA-2 epidemiological survey. Nauchno-prakticheskaya revmatologiya = Rheumatology science and practice. 2007;(4):4–9. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484- 2014-600-606; Igarashi A, Kikuchi S, Konno S, Olmarker K. Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine (Phila Pa 1976). 2004 Oct 1;29(19):2091–5.; Genevay S, Finckh A, Payer M, et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine (Phila Pa 1976). 2008 Sep 1;33(19):2041–6. doi:10.1097/BRS.0b013e318183bb86.; Cuellar JM, Golish SR, Reuter MW, et al. Cytokine evaluation in individuals with low back pain using discographic lavage. Spine J. 2010 Mar;10(3):212–8. doi:10.1016/j.spinee. 2009.12.007.; Schaible HG. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep. 2012 Dec;14(6):549–56. doi:10.1007/s11926-012-0279-x.; Walsh DA, Bonnet CS, Turner EL, et al. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage. 2007 Jul; 15(7):743–51. Epub 2007 Mar 21.; Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001 Jun;44(6):1237–47.; Alvarez-Soria MA, Largo R, Santillana J, et al. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis. 2006 Aug;65(8):998–1005. Epub 2006 Feb 13.; McCarberg BH, Ruoff GE, Tenzer- Iglesias P, Weil AJ. Diagnosis and treatment of low-back pain because of paraspinous muscle spasm: a physician roundtable. Pain Med. 2011 Nov;12 Suppl 4:S119–27. doi:10.1111/j.1526-4637.2011.01253.x.; Lund JP, Donga R, Widmer CG, Stohler CS. The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity. Can J Physiol Pharmacol. 1991 May;69(5):683–94.; Roland M. A critical review of the evidence for pain-spasm-pain cycle in spinal disorders. Clin Biomech (Bristol, Avon). 1986 May;1(2):102–9. doi:10.1016/0268- 0033(86)90085-9.; Iglesias-Gonzalez JJ, Munoz-Garcia MT, Rodrigues-de-Souza DP, et al. Myofascial trigger points, pain, disability, and sleep quality in patients with chronic nonspecific low back pain. Pain Med. 2013 Dec;14(12):1964–70. doi:10.1111/pme.12224. Epub 2013 Aug 15.; Ramsook RR, Malanga GA. Myofascial low back pain. Curr Pain Headache Rep. 2012 Oct;16(5):423–32. doi:10.1007/s11916-012-0290-y.; Fisher NM, Pendergast DR. Reduced muscle function in patients with osteoarthritis. Scand J Rehabil Med. 1997 Dec;29(4):213–21.; Arokoski MH, Arokoski JP, Haara M, et al. Hip muscle strength and muscle cross sectional area in men with and without hip osteoarthritis. J Rheumatol. 2002 Oct;29(10):2185–95.; Blume C, Wang SS. Comparison of changes in supraspinatus muscle thickness in persons with subacromial impingement syndrome and asymptomatic adults. Physiother Theory Pract. 2014 Nov;30(8):544–51. doi:10.3109/09593985.2014.902522. Epub 2014 Mar 28.; Silldorff MD, Choo AD, Choi AJ, et al. Effect of supraspinatus tendon injury on supraspinatus and infraspinatus muscle passive tension and associated biochemistry. J Bone Joint Surg Am. 2014 Oct 15;96(20):e175. doi:10.2106/JBJS.M.01315.; Thomopoulos S, Parks WC, Rifkin DB, Derwin KA. Mechanisms of tendon injury and repair. J Orthop Res. 2015 Jan 29. doi:10.1002/jor.22806. Epub ahead of print.; Millar NL, Hueber AJ, Reilly JH, et al. Inflammation is present in early human tendinopathy. Am J Sports Med. 2010 Oct;38(10):2085–91. doi:10.1177/0363546510372613. Epub 2010 Jul 1.; McGonagle D, Benjamin M. Entheses, entehesitis and enthesopathy. Report of heumatic diseases, series 6, autumn 2009, №4. На сайте: www.arc.org.uk/arthinfo/rdr.asp 33. Benjamin M., McGonagle D. Histopathologic Changes at «Synovio- Entheseal Complexes» Suggesting a Novel Mechanism for Synovitis in Osteoarthritis and Spondylarthritis. Arthritis Rheum. 2007 Nov;56(11):3601–9.; Gotoh M, Hamada K, Yamakawa H, et al. Interleukin-1-induced glenohumeral synovitis and shoulder pain in rotator cuff diseases. J Orthop Res. 2002 Nov;20(6):1365–71.; Voloshin I, Gelinas J, Maloney MD, et al. Proinflammatory cytokines and etalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy. 2005 Sep;21(9):1076.e1–1076.e9.; Haviv B, Bronak S, Thein R. The complexity of pain around the knee in patients with osteoarthritis. Isr Med Assoc J. 2013 Apr;15(4):178–81.; Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013 Jan;21(1):10–5. doi:10.1016/j.joca.2012.09.012. Epub 2012 Oct 4.; Edmonds S. Therapeutic targets for osteoarthritis. Maturitas. 2009 Jul 20;63(3):191–4. doi:10.1016/j.maturitas. 2009.03.015. Epub 2009 May 6.; Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005 Sep;17(5):624–8.; Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011 Dec;13(6):513–20. doi:10.1007/s11926-011- 0206-6.; Tsao H, Tucker KJ, Coppieters MW, Hodges PW. Experimentally induced low back pain from hypertonic saline injections into lumbar interspinous ligament and erector spinae muscle. Pain. 2010 Jul;150(1):167–72. doi:10.1016/j.pain.2010.04.023. Epub 2010 May 26.; Panjabi MM. A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction. Eur Spine J. 2006 May;15(5):668–76. Epub 2005 Jul 27.; Longo UG, Berton A, Khan WS, et al. Histopathology of rotator cuff tears. Sports Med Arthrosc. 2011 Sep;19(3):227–36. doi:10.1097/JSA.0b013e318213bccb.; Ko JY, Wang FS. Rotator cuff lesions with shoulder stiffness: updated pathomechanisms and management. Chang Gung Med J. 2011 Jul-Aug;34(4):331–40.; Raastad J, Reiman M, Coeytaux R, et al. The association between lumbar spine adiographic features and low back pain: A systematic review and meta-analysis. Semin Arthritis Rheum. 2015 Apr;44(5):571–85. doi:10.1016/j.semarthrit.2014.10.006. Epub 2014 Dec 8.; de Schepper EI, Damen J, van Meurs JB, et al. The association between lumbar disc degeneration and low back pain: the influence of age, gender, and individual radiographic features. Spine (Phila Pa 1976). 2010 Mar 1;35(5):531–6. doi:10.1097/BRS.0b013e3181aa5b33.; Scheele J, de Schepper EI, van Meurs JB, et al. Association between spinal morning stiffness and lumbar disc degeneration: the Rotterdam Study. Osteoarthritis Cartilage. 2012 Sep;20(9):982–7. doi:10.1016/j.joca. 2012.05.011. Epub 2012 Jun 12.; Beresford ZM, Kendall RW, Willick SE. Lumbar facet syndromes. Curr Sports Med Rep. 2010 Jan-Feb;9(1):50–6. doi:10.1249/JSR.0b013e3181caba05.; Cohen SP, Raja SN. Pathogenesis, diagnosis, and treatment of lumbar zygapophysial (facet) joint pain. Anesthesiology. 2007 Mar;106(3):591–614.; Туровская ЕФ, Алексеева ЛИ, Филатова ЕГ. Современные представления о патогенетических механизмах боли при остеоартрозе. Научно-практическая ревматология. 2014;52(4):438–44. [Turovskaya EF, Alekseeva LI, Filatova EG. Current ideas about the pathogenetic mechanisms of pain in osteoarthrosis. Nauchno-prakticheskaya revmatologiya = Rheumatology science and practice. 2014;52(4):438–44. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2014-438-444; Mease PJ, Hanna S, Frakes EP, Altman RD. Pain mechanisms in osteoarthritis: understanding the role of central pain and urrent approaches to its treatment. J Rheumatol. 2011 Aug;38(8):1546–51. doi:10.3899/jrheum.100759. Epub 2011 Jun 1.; Hochman JR, French MR, Bermingham SL, Hawker GA. The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken). 2010 Jul;62(7):1019–23. doi:10.1002/acr.20142.; Fishbain DA, Cole B, Lewis JE, Gao J. What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review. Pain Med. 2014 Jan;15(1):4–15. doi:10.1111/pme.12229. Epub 2013 Oct 4.; Coombes BK, Bisset L, Vicenzino B. Thermal hyperalgesia distinguishes those with severe pain and disability in unilateral lateral epicondylalgia. Clin J Pain 2012;28:595–601.; Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013 Jun 1;87(11):766–72.; Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009 May- Jun;31(3):206–19. doi:10.1016/j.genhosppsych. 2008.12.006. Epub 2009 Mar 4.; Brune K, Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Res. 2015 Feb 20;8:105–18. doi:10.2147/JPR.S75160. eCollection 2015.; Каратеев АЕ, Насонов ЕЛ, Яхно НН и др. Клинические рекомендации «Рациональное применение нестероидных противовоспалительных препаратов (НПВП) в клинической практике». Современная ревматология. 2015;(1):4–23. [Karateev AE, Nasonov EL, Yakhno NN, et al. Clinical guidelines «Rational use of nonsteroidal antiinflammatory drugs (NSAIDs) in clinical practice». Sovremennaya revmatologiya = Modern Rheumatology Journal. 2015;(1):4–23. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2015- 1-4-23; Moore RA, Moore OA, Derry S, et al. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis. 2010 Feb;69(2):374–9. doi:10.1136/ard.2009.107805. Epub 2009 Apr 12.; Goldstein JL, Cryer B. Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies. Drug Healthc Patient Saf. 2015 Jan 22;7:31–41. doi:10.2147/DHPS.S71976. eCollection 2015.; Harirforoosh S, Asghar W, Jamali F. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications. J Pharm Pharm Sci. 2013;16(5):821–47.; Lemmel EM, Leeb B, De Bast J, Aslanidis S. Patient and physician satisfaction with acec-lofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the management of inflammatory pain. Curr Med Res Opin. 2002;18(3):146–53.; Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs. 2001;61(9):1351–78.; Hаskinsson E., Irani M., Murray F. A large prospective open-label, multi-centre SAMM study, comparing the safety of aceclofenac with diclofenac in patients with rheumatic disease. Eur J Rheumatol Inflam. 2000;17:1–7.; Шарапова ЕП, Кашеварова НГ, Аникин СГ и др. Применение новых форм ацеклофенака при остеоартрозе в реальной клинической практике. Современная ревматология. 2014;(1):73-6. [Sharapova EP, Kashevarova NG, Anikin SG, et al. The use of new aceclofenac dosage forms in patients with osteoarthrosis in reallife clinical practice. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2014;(1):73-6. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2014-1-73-76; Ikeda Y, Shimada K, Teramoto T, et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk actors: a randomized clinical trial. JAMA. 2014 Dec 17;312(23):2510–20. doi:10.1001/jama.2014.15690.; Brotons C, Benamouzig R, Filipiak KJ, et al. A Systematic Review of Aspirin in Primary Prevention: Is It Time for a New Approach? Am J Cardiovasc Drugs. 2014 Dec 12. Epub ahead of print.; Hennekens CH, Dalen JE. Aspirin in the primary prevention of cardiovascular disease: Current knowledge and future research needs. Trends Cardiovasc Med. 2014 ov;24(8):360–6. doi:10.1016/j.tcm.2014.08.006. Epub 2014 Sep 1.; Day RO, Graham GG, Whelton A. The position of paracetamol in the world of analgesics. Am J Ther. 2000 Mar;7(2):51–4.; Prescott LF. Paracetamol: past, present and future. Am J Ther. 2000 Mar;7(2):143–7.; Towheed TE, Maxwell L, Judd MG, et al. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004257.; Garcia Rodriguez LA, Hernandez-Diaz S. Relative risk of upper gastrointestinal omplications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology. 2001 Sep;12(5):570–6.; Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, nd the risk of cardiovascular events. Circulation. 2006 Mar 28;113(12):1578–87. Epub 2006 Mar 13.; Dedier J, Stampfer MJ, Hankinson SE, et al. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002 Nov;40(5):604–8; discussion 601–3.; Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med. 2007 Feb 26;167(4):394–9.; Ong CK, Seymour RA, Lirk P, Merry AF. Combining paracetamol (acetaminophen) with nonsteroidal antiinflammatory drugs: a qualitative systematic review of analgesic efficacy for acute postoperative pain. Anesth Analg. 2010 Apr 1;110(4):1170–9. doi:10.1213/ANE.0b013e3181cf9281.Epub 2010 Feb 8.; McQuay H, Edwards J. Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain. Eur J Anaesthesiol Suppl. 2003;28:19–22.; Cepeda MS, Camargo F, Zea C, Valencia L. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol. 2007 Mar;34(3):543–55.; Rosenberg MT. The role of tramadol ER in the treatment of chronic pain. Int J Clin Pract. 2009 Oct;63(10):1531–43. doi:10.1111/j.1742-1241.2009.02161.x.; Peloso PM, Fortin L, Beaulieu A, et al. Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, ouble blind, placebo controlled trial. J Rheumatol. 2004 Dec;31(12):2454–63.; Perrot S, Krause D, Crozes P, et al. Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in pa-tients with subacute low back pain: a multicenter, randomized, double- blind, parallel-group, 10-day treatment study. Clin Ther. 2006 Oct;28(10):1592–606.; Tjä derborn M, Jö nsson AK, Ahlner J, Hä gg S. Tramadol dependence: a survey of spontaneously reported cases in Sweden. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1192–8. doi:10.1002/pds.1838.; O'Donnell JB, Ekman EF, Spalding WM, et al. The effectiveness of a weak opioid edication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, oubleblind, 6-week studies. J Int Med Res. 2009 Nov-Dec;37(6):1789–802.; Beaulieu AD, Peloso PM, Haraoui B, et al. Once-daily, controlled-release tramadol and sus-tained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized ontrolled tri-al. Pain Res Manag. 2008 Mar- Apr;13(2):103–10.; van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003;(2):CD004252.; Гурак СВ, Парфенов ВА, Борисов КН. Мидокалм в комплексной терапии острой поясничной боли. Боль. 2006;(3):27–30. [Gurak SV, Parfenov VA, Borisov KN. Mydocalm in complex therapy of acute low back pain. Bol'. 2006;(3):27–30. (In Russ.)].; Ласло Х, Мелинда М, Жолт С, Иштван З. Лечение острой поясничной боли Мидокалмом. Результаты международного мультицентрового рандомизированного двойного-слепого плацебо-контролируемого клинического исследования. Русский медицинский журнал. 2003;(5):246–9. [Laslo Kh, Melinda M, Zholt S, Ishtvan Z. Treatment of acute lumbar pain with Mydocalm. The results of an international multicenter randomized double- blind placebo-controlled clinical studies. Russkii meditsinskii zhurnal. 2003;(5):246–9. (In Russ.)].; Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain. 1996 Oct;67(2–3):417–25.; Кукушкин МЛ. Современный взгляд на механизм действия Мидокалма. Consilium medicum. 2013;(2):89–94. [Kukushkin ML. A modern view of the mechanism of action of Mydocalm. Consilium medicum. 2013;(2):89–94. (In Russ.)].; Шарапова ЕП, Алексеева ЛИ, Зайцева ЕМ и др. Применение миорелаксантов в комплексной терапии остеоартроза. Consilium medicum. 2008;(2):30–2. [Sharapova EP, Alekseeva LI, Zaitseva EM, et al. The use of muscle relaxants in the treatment of osteoarthritis. Consilium medicum. 2008;(2):30–2.[(In Russ.)].; Hameed F, Ihm J. Injectable medications for osteoarthritis. PMR. 2012 May;4(5 Suppl):S75–81. doi:10.1016/j.pmrj.2012.02.010. 92. Habib GS, Saliba W, Nashashibi M. Local ffects of intra-articular corticosteroids. Clin Rheumatol. 2010 Apr;29(4):347–56. doi:10.1007/s10067-009-1357-y. Epub 2010 Jan 26.; Dean BJ, Lostis E, Oakley T, et al. Risks and Benefits of Glucocorticoid Treatment for Tendinopathy: A Systematic Review of the Effects of Local Glucocorticoid on Tendon. Semin Arthritis Rheum. 2014 Feb;43(4):570–6. doi:10.1016/j.semarthrit. 2013.08.006. Epub 2013 Sep 26.; Tallia AF, Cardone DA. Diagnostic and therapeutic injection of the shoulder region. Am Fam Physician. 2003 Mar 15;67(6):1271–8.; Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010 Nov 20;376(9754):1751–67. doi:10.1016/S0140- 6736(10)61160-9. Epub 2010 Oct 21.; Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005328.; McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363–88. doi:10.1016/j.joca. 2014.01.003. Epub 2014 Jan 24.; Насонов ЕЛ, редактор. Ревматология. Клинические рекомендации. Москва: ГЭ- ОТАР-Медиа; 2010. 752 с. [Nasonov EL, editor. Revmatologiya. Klinicheskie rekomendatsii [Rheumatilogy. Clinical guidelines]. Moscow: GEOTAR-Media; 2010. 752 p.]; Farooq MA, Devitt AT. Perceived efficacy and risks of infection following intra-articular injections: a survey of orthopaedic surgeons. Ir J Med Sci. 2005 Jan-Mar;174(1):26–32.; Charalambous CP, Tryfonidis M, Sadiq S, et al. Septic arthritis following intraarticular glucocorticoid injection of the knee – a survey of current practice regarding antiseptic technique used during intra-articular glucocorticoid injection of the knee. Clin Rheumatol. 2003 Dec;22(6):386–90. Epub 2003 Oct 15.; Younes M, Neffati F, Touzi M, et al. Systemic effects of epidural and intra-articular glucocorticoid injections in diabetic and non-diabetic patients. Joint Bone Spine. 2007 Oct;74(5):472–6. Epub 2007 Jul 6.; Moon HJ, Choi KH, Lee SI, et al. Changes in blood glucose and cortisol levels after epidural or shoulder intraarticular glucocorticoid injections in diabetic or nondiabetic patients. Am J Phys Med Rehabil. 2014 May;93(5):372–8. doi:10.1097/PHM.0000000000000001.; Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. Efficacy and Safety of Neuromodulators in Inflammatory Arthritis: A Cochrane Systematic Review. J Rheumatol Suppl. 2012 Sep;90:28–33. doi:10.3899/jrheum.120339.; Алексеева ЛИ. Препараты замедленного действия в лечении остеоартроза. Русский Медицинский Журнал. 2012;(7):389–94. [Alekseeva LI. The slowacting drugs in the treatment of osteoarthritis. Russkii Meditsinskii Zhurnal. 2012;(7):389–94. (In Russ.)].; Imagawa K, de Andres MC, Hashimoto K, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-κB) inhibitor on primary human chondrocytes-- implications for osteoarthritis. Biochem Biophys Res Commun. 2011 Feb 18;405(3):362–7. doi:10.1016/j.bbrc.2011.01.007. Epub 2011 Jan 8.; Calamia V, Ruiz-Romero C, Rocha B, et al. Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther. 2010;12(4):R138. doi:10.1186/ar3077. Epub 2010 Jul 13.; Au R, Au A, Rashmir-Raven A, rondoza C. Inhibition proinflammatory gene expression n chondrocytes, monocytes, and fibroblasts by combination of avocado soybean unsaponiables, glucosamine and chondroitin sulfate. FASEB. 2007;21(6):702–7.; Towheed TE, Maxwell L, Anastassiades TP, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002946.; Reichenbach S, Sterchi R, Scherer M, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med. 2007 Apr 17;146(8):580–90.; Fidelix TS, Soares BG, Trevisani VF. Diacerein for osteoarthritis. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005117.; Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of vocadosoybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2008 Apr;16(4):399–408. Epub 2007 Nov 26.; Koes BW, van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the anagement of non-specific low back pain in primary care. Eur Spine J. 2010 Dec;19(12):2075–94.; Englbrecht M, Tarner IH, van der Heijde DM, et al. Measuring Pain and Efficacy of Pain Treatment in Inflammatory Arthritis: A Systematic Literature Review J Rheumatol Suppl. 2012 Sep;90:3–10. doi:10.3899/jrheum.120335.; Ostelo RW, de Vet HC. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol. 2005 Aug;19(4):593–607.; Stauffer ME, Taylor SD, Watson DJ, et al. Definition of nonresponse to analgesic reatment of arthritic pain: an analytical literature review of the smallest detectable ifference, the minimal detectable change, and the minimal clinically important difference n hepain visual analog scale. Int J Inflam. 2011;2011:231926. doi:10.4061/2011/ 231926. Epub 2011 May 5.; Salaffi F, Stancati A, Silvestri CA, et al. Minimal clinically important changes in chronic musculoskel-etal pain intensity measured on a numerical rating scale. Eur J Pain. 2004 Aug;8(4):283–91.; Cepeda MS1, Africano JM, Polo R, et al. What decline in pain intensity is meaningful to patients with acute pain? Pain. 2003 Sep;105(1–2):151–7.; Maigne JY, Cornelis P, Chatellier G. Lower back pain and neck pain: is it possible to identify the painful side by palpation only? Ann Phys Rehabil Med. 2012 Mar;55(2):103–11. doi:10.1016/j.rehab.2012.01.001. Epub 2012 Feb 2.

Διαθεσιμότητα: https://mrj.ima-press.net/mrj/article/view/622
https://doi.org/10.14412/1996-7012-2015-2-37-50

Nonsteroidal anti-inflammatory drugs as the first step in treating musculoskeletal pain ; Нестероидные противовоспалительные препараты как первая ступень при лечении скелетно-мышечной боли

Συγγραφείς: Andrei Evgenyevich Karateev, A. S. Misiyuk, Андрей Евгеньевич Каратеев, А. С. Мисиюк

Πηγή: Modern Rheumatology Journal; Том 9, № 3 (2015); 61-69 ; Современная ревматология; Том 9, № 3 (2015); 61-69 ; 2310-158X ; 1996-7012 ; 10.14412/1996-7012-2015-3

Θεματικοί όροι: ацеклофенак, musculoskeletal pain, pathogenesis, analgesic therapy, aceclofenac, скелетно-мышечная боль, патогенез, анальгетическая терапия

Περιγραφή αρχείου: application/pdf

Relation: https://mrj.ima-press.net/mrj/article/view/641/628; Яхно НН, Кукушкин МЛ, редакторы. Боль (практическое руководство для врачей). Москва: Издательство РАМН; 2012. 512 c. [Yakhno NN, Kukushkin ML, editors. Bol' (prakticheskoe rukovodstvo dlya vrachei) [Pain (a practical manual for doctors)]. Moscow: Izdatel'stvo RAMN; 2012. 512 p.]; Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–56. Epub 2003 Nov 14.; Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287–333. Epub 2005 Aug 10.; Насонова ВА, Фоломеева ОМ, Эрдес ШФ. Ревматические заболевания в Российской Федерации в начале XXI века глазами статистики. Терапевтический архив. 2009;(6):5–10. [Nasonova VA, Folomeeva OM, Erdes ShF. Rheumatic diseases in the Russian Federation in the beginning of the XXI century through the eyes of statistics. Terapevticheskii arkhiv. 2009;(6):5–10. (In Russ.)].; Балабанова РМ, Эрдес ШФ. Распространенность ревматических заболеваний в России в 2012–2013 гг. Научно-практическая ревматология. 2015;53(2):120–4. [Balabanova RM, Erdes ShF. The incidence and prevalence of rheumatic diseases in Russia in 2012–2013. Nauchno-prakticheskaya revmatologiya = Rhematology Science and Practice. 2015;53(2):120–4. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2015-120-124; Каратеев АЕ. Болезни костно-мышечной системы в практике 2102 врачей разных специальностей: структура патологии и мнение специалистов об эффективности НПВП (предварительные данные эпидемиологического исследования КОРОНА-2). Consilium medicum. 2013;(9):95–100. [Karateev AE. Diseases of the musculoskeletal system in practice of 2102 doctors of different specialties: thestructure of pathology and the opinions of experts about the effectiveness of NSAIDs (preliminary data from epidemiological study CORONA-2). Consilium medicum. 2013;(9):95–100. (In Russ.)].; Staud R. Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia. Curr Rheumatol Rep. 2011 Dec;13(6):513–20. doi:10.1007/s11926-011-0206-6.; Felson DT. The sources of pain in knee osteoarthritis. Curr Opin Rheumatol. 2005 Sep;17(5):624–8.; Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013 Jun 1;87(11):766–72.; Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry. 2009 MayJun;31(3):206–19. doi:10.1016/j.genhosppsych. 2008.12.006. Epub 2009 Mar 4.; McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363–88. doi:10.1016/j.joca.2014.01.003. Epub 2014 Jan 24.; Bruyere O, Cooper C, Pelletier JP, et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum. 2014 Dec;44(3):253–63. doi:10.1016/j.semarthrit.2014.05.014. Epub 2014 May 14.; Koes BW, van Tulder M, Lin CW, et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care. Eur Spine J. 2010 Dec;19(12):2075–94.; Andersen JC. Is immediate imaging important in managing low back pain? J Athl Train. 2011 Jan-Feb;46(1):99–102. doi:10.4085/1062-6050-46.1.99.; Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet. 2009 Feb 7; 373(9662):463–72. doi:10.1016/S0140-6736(09)60172-0.; Jarvik J, Gold L, Comstock B, et al. Association of Early Imaging for Back Pain With Clinical Outcomes in Older Adults. JAMA. 2015 Mar 17;313(11):1143–53. doi:10.1001/jama.2015.1871.; Igarashi A, Kikuchi S, Konno S, Olmarker K. Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders. Spine (Phila Pa 1976). 2004 Oct 1;29(19):2091–5.; Genevay S, Finckh A, Payer M, et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc. Spine (Phila Pa 1976). 2008 Sep 1;33(19):2041–6. doi:10.1097/BRS.0b013e318183bb86.; Walsh D, Bonnet C, Turner E, et al. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage. 2007 Jul;15(7):743–51. Epub 2007 Mar 21.; Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001 Jun;44(6):1237–47.; Alvarez-Soria MA, Largo R, Santillana J, et al. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac. Ann Rheum Dis. 2006 Aug;65(8):998–1005. Epub 2006 Feb 13.; McCarberg BH, Ruoff GE, TenzerIglesias P, Weil AJ. Diagnosis and treatment of low-back pain because of paraspinous muscle spasm: a physician roundtable. Pain Med. 2011 Nov;12 Suppl 4:S119–27. doi:10.1111/j.1526-4637.2011.01253.x.; Roland M. A critical review of the evidence for pain-spasm-pain cycle in spinal disorders. Clin Biomech. 1986;1:102–109. doi:10.1016/0268-0033(86)90085-9.; Ramsook RR, Malanga GA. Myofascial low back pain. Curr Pain Headache Rep. 2012 Oct;16(5):423–32. doi:10.1007/s11916-012-0290-y.; Fisher NM, Pendergast DR. Reduced muscle function in patients with osteoarthritis. Scand J Rehabil Med. 1997 Dec;29(4):213–21.; Arokoski MH, Arokoski JP, Haara M, et al. Hip muscle strength and muscle cross sectional area in men with and without hip osteoarthritis. J Rheumatol. 2002 Oct;29(10):2185–95.; Blume C, Wang SS. Comparison of changes in supraspinatus muscle thickness in persons with subacromial impingement syndrome and asymptomatic adults. Physiother Theory Pract. 2014 Nov;30(8):544–51. doi:10.3109/09593985.2014.902522. Epub 2014 Mar 28.; Silldorff MD, Choo AD, Choi AJ, et al. Effect of supraspinatus tendon injury on supraspinatus and infraspinatus muscle passive tension and associated biochemistry. J Bone Joint Surg Am. 2014 Oct 15;96(20):e175. doi:10.2106/JBJS.M.01315. 29. Millar NL, Hueber AJ, Reilly JH, et al. Inflammation is present in early human tendinopathy. Am J Sports Med. 2010;38(10):2085–91. doi:10.1177/0363546510372613. Epub 2010 Jul 1.; Benjamin M, McGonagle D. Histopathologic Changes at «Synovio–Entheseal Complexes» Suggesting a Novel Mechanism for Synovitis in Osteoarthritis and Spondylarthritis. Arthritis Rheum. 2007 Nov;56(11):3601–9.; Gotoh M, Hamada K, Yamakawa H, et al. Interleukin-1-induced glenohumeral synovitis and shoulder pain in rotator cuff diseases. J Orthop Res. 2002 Nov;20(6):1365–71.; Voloshin I, Gelinas J, Maloney MD, et al. Proinflammatory cytokines and metalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy. 2005 Sep;21(9):1076.e1–1076.e9.; Felson DT. Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage. 2013 Jan;21(1):10–5. doi:10.1016/j.joca.2012.09. 012. Epub 2012 Oct 4.; Tsao H, Tucker KJ, Coppieters MW, Hodges PW. Experimentally induced low back pain from hypertonic saline injections into lumbar interspinous ligament and erector spinae muscle. Pain. 2010 Jul;150(1):167–72. doi:10.1016/j.pain.2010.04.023. Epub 2010 May 26.; Panjabi MM. A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction. Eur Spine J. 2006 May;15(5):668–76. Epub 2005 Jul 27.; Mease PJ, Hanna S, Frakes EP, Altman RD. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol. 2011 Aug;38(8):1546–51. doi:10.3899/jrheum.100759. Epub 2011 Jun 1.; Hochman JR, French MR, Bermingham SL, Hawker GA. The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken). 2010 Jul;62(7):1019–23. doi:10.1002/acr.20142.; Fishbain DA, Cole B, Lewis JE, Gao J. What is the evidence that neuropathic pain is present in chronic low back pain and soft tissue syndromes? An evidence-based structured review. Pain Med. 2014 Jan;15(1):4–15. doi:10.1111/pme.12229. Epub 2013 Oct 4.; Каратеев АЕ, Насонов ЕЛ, Яхно НН и др. Клинические рекомендации: рациональное использование НПВП в клинической практике. Современная ревматология. 2015;9(1):4–23. [Karateev AE, Nasonov EL, Yakhno NN i dr. Clinical guidelines «Rational use of nonsteroidal antiinflammatory drugs (NSAIDs) in clinical practice». Sovremennaya revmatologiya = Modern Rheumatology Journal. 2015;9(1):4–23. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2015-1-4-23; O'Donnell JB, Ekman EF, Spalding WM, et al. The effectiveness of a weak opioid medication versus a cyclo-oxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug in treating flare-up of chronic low-back pain: results from two randomized, doubleblind, 6-week studies. J Int Med Res. 2009 Nov-Dec;37(6):1789–802.; DeLemos BP, Xiang J, Benson C, et al. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. Am J Ther. 2011 May;18(3):216–26. doi:10.1097/MJT.0b013e3181cec307.; Bjordal J, Klovning A, Ljunggren A, Slordal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain. 2007 Feb;11(2):125–38. Epub 2006 May 8.; Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000396. doi:10.1002/14651858.CD000396.pub3.; Boudreault J, Desmeules F, Roy JS, et al. The efficacy of oral non-steroidal anti-inflammatory drugs for rotator cuff tendinopathy: a systematic review and meta-analysis. J Rehabil Med. 2014 Apr;46(4):294–306. doi:10.2340/16501977-1800.; Насонова ВА. Ацеклофенак (аэртал) в ревматологической практике. Терапевтический архив. 2005;(5):87–90. [Nasonova VA. Aceclofenac (airtal) in rheumatologic practice. Terapevticheskii arkhiv. 2005;(5):87–90. (In Russ.)].; Legrand E. Aceclofenac in the management of inflammatory pain. Expert Opin Pharmacother. 2004 Jun;5(6):1347–57.; Reginster JY, Paul I, Henrotin Y. What is the role of aceclofenac in the therapeutic arsenal against chronic osteoarthritis pathologies? Rev Med Liege. 2001 Jul;56(7):484–8.; Saraf S. Aceclofenac: a рotent nonsteroidal anti-inflammatory drug. Latest Rev. 2006;4(3).; Hinz B, Rau T, Auge D, et al. Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. Clin Pharmacol Ther. 2003 Sep;74(3):222–35.; Dingle J. The effects of NSAID on the matrix of human articular cartilages. Z Rheumatol. 1999 Jun;58(3):125–9.; Blot L, Marcelis A, Devogelaer JP, Manicourt DH. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human car-tilage. Br J Pharmacol. 2000 Dec;131(7):1413–21.; Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs. 2001;61(9):1351–78.; Jyothsna K, Deshpande N, Vijayalakshmi G. Efficacy and safety of diclofenac sodium and aceclofenac in controlling post extraction dental pain: A randomised open label comparative study. J Pharmacol Toxicol. 2011;6(5):541–7. DOI:10.3923/jpt.2011.541.547; Chunduri NS, Kollu T, Goteki VR, et al. Efficacy of aceclofenac and diclofenac sodium for relief of postoperative pain after third molar surgery: A randomised open label comparative study. J Pharmacol Pharmacother. 2013 Apr;4(2):144–5. doi:10.4103/0976-500X.110910.; Batlle-Gualda E, Roman Ivorra J, Martin-Mola E, et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage. 2007 Aug;15(8):900–8. Epub 2007 Mar 26.; Ward DE, Veys EM, Bowdler JM, Roma J. Comparison of aceclofenac with diclofenac in the treatment of osteoarthritis. Clin Rheumatol. 1995 Nov;14(6):656–62.; Kornasoff D, Frerick H, Bowdler J, Montull E. Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis. Clin Rheumatol. 1997 Jan;16(1):32–8.; Perez Busquier M, Calero E, Rodriguez M, et al. Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis. Clin Rheumatol. 1997 Mar;16(2):154–9.; Pareek A, Chandurkar N. Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis. Curr Med Res Opin. 2013 Jul;29(7):849–59. doi:10.1185/03007995.2013.795139. Epub 2013 Apr 30.; Martin-Mola E, Gijon-Banos J, Ansoleaga JJ. Aceclofenac in comparison to ketoprofen in the treatment of rheumatoid arthritis. Rheumatol Int. 1995;15(3):111–6.; Schattenkirchner M, Milachowski KA. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin Rheumatol. 2003 May;22(2):127–35.; Lemmel EM, Leeb B, De Bast J, Aslanidis S. Patient and physician satisfaction with acec-lofenac: results of the European Observational Cohort Study (experience with aceclofenac for inflammatory pain in daily practice). Aceclofenac is the treatment of choice for patients and physicians in the management of inflammatory pain. Curr Med Res Opin. 2002;18(3):146–53.; Hаskinsson E., Irani M., Murray F. A large prospective open-label, multi-centre SAMM study, comparing the safety of aceclofenac with diclofenac in patients with rheumatic disease. Eur J Rheumatol Inflam. 2000;17:1–7.; Yanagawa A., Kudo T., Shimada J., et al. Endoscopic evaluation of Aceclofenacinduced gastroduodenal mucosal damage: a double-blind comparisonr with sodium Diclofenac and Placebo. Jap J Rheumatol. 1998;8:249–59.; Grau M, Guasch J, Montero JL, et al. Pharmacology of the potent new nonsteroidal anti-inflammatory agent aceclofenac. Arzneimittelforschung. 1991 Dec;41(12):1265–76.; Каратеев АЕ, Денисов ЛН, Маркелова ЕИ и др. Результаты клинического исследования АЭРОПЛАН (анализ эффективности и риска осложнений при лечении артрита ацеклофенаком и нимесулидом). Consilium Medicum. 2013;15(2):52–7. [Karateev AE, Denisov LN, Markelova EI, et al. Results of clinical research AEROPLAN (analysis of the effectiveness and risk of complications in the treatment of the arthritis with aceclofenac and nimesulide). Consilium Medicum. 2013;15(2):52–7. (In Russ.)].; Каратеев АЕ. Сравнительная оценка влияния нимесулида на верхние отделы желудочно-кишечного тракта. Лечащий врач. 2014;(7);51–5. [Karateev AE. Comparative evaluation of the effect of nimesulide on the upper gastrointestinal tract. Lechashchii vrach. 2014;(7);51–5. (in Russ.)].; Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012 Dec 1;35(12):1127–46. doi:10.2165/11633470-000000000-00000.; Garcia-Poza P, de Abajo F, Gil M, et al. Risk of ischemic stroke associated with nonsteroidal anti-inflammatory drugs and paracetamol: a population-based case-control study. J Thromb Haemost. 2015 May;13(5):708–18. doi:10.1111/jth.12855. Epub 2015 Feb 24.; Helin-Salmivaara A, Virtanen A, Vesalainen R, et al. NSAID use and the risk of hospitali-zation for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J. 2006 Jul;27(14):1657–63. Epub 2006 May 26.; Гришаева ГП, Балабанова РМ. Опыт применения аэртала (ацеклофенака) при лечении ревматических заболеваний. Трудный пациент. 2005;(2):56–9. [Grishaeva GP, Balabanova RM. The experience of using airtal (aceclofenac) in the treatment of rheumatic diseases. Trudnyi patsient. 2005;(2):56–9. (In Russ.)].; Лила АМ. Применение Аэртала (ацеклофенака) в клинической практике. Русский Медицинский Журнал. 2009;(4):291–5. [Lila AM. The experience of using airtal (aceclofenac) in clinical practice. Russkii Meditsinskii Zhurnal. 2009;(4):291–5. (In Russ.)].; Насонова ВА, Каратеев АЕ. Симптоматическая терапия боли при ревматических заболеваниях: место ацеклофенака. Современная ревматология. 2009;3(3):58–65. [Nasonova VA, Karateev AE. Symptomatic therapy for pain in rheumatic diseases: a place of aceclofenac. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2009;3(3):58–65. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2009-560; Замятина ЕА, Багирова ГГ. Применение мелоксикама (мовалиса) и ацеклофенака (аэртала) у лиц пожилого возраста с остеоартрозом. Известия высших учебных заведений. Приволжский регион. Медицинские науки. 2012;21(1):40–6. [Zamyatina EA, Bagirova GG. The use of meloxicam (Movalis) and aceclofenac (airtal) in the elderly with osteoarthritis. Izvestiya vysshikh uchebnykh zavedenii. Privolzhskii region. Meditsinskie nauki. 2012;21(1):40–6. (In Russ.)].; Мартусевич НА, Алешкевич АИ, Сидоренко ВА, Сергейчик ОВ. Сравнительная оценка эффективностии безопасности применения лекарственных средств ацеклофенак (Airtal®) и диклофенак (Diclopol®) у пациентов с гонартрозом I-II рентгенологической стадии. Медицинские Новости. 2012;(8):55–8. [Martusevich NA, Aleshkevich AI, Sidorenko VA, Sergeichik OV. Comparative assessment of the efficacy and safety of use of aceclofenac (Airtal®) and diclofenac (Diclopol®) in patients with gonarthrosis of I-II radiographic stages. Meditsinskie Novosti. 2012;(8):55–8. (In Russ.)].; Pareek A, Chandurkar N, Gupta A, at al. Efficacy and safety of aceclofenac-cr and aceclofenac in the treatment of knee osteoarthritis: a 6-week, comparative, randomized, multicentric, double-blind study. J Pain. 2011 May;12(5):546–53. doi:10.1016/j.jpain.2010.10.013. Epub 2011 Feb 1.; Moon YW, Kang SB, Kim TK, Lee MC. Efficacy and Safety of Aceclofenac Controlled Release in Patients with Knee Osteoarthritis: A 4-week, Multicenter, Randomized, Comparative Clinical Study. Knee Surg Relat Res. 2014 Mar;26(1):33–42. doi:10.5792/ksrr.2014.26.1.33. Epub 2014 Feb 27.; Алексеева ЛИ, Шарапова ЕП, Кашеварова НГ и др. Применение новых форм ацеклофенака при остеоартрозе в реальной клинической практике. Современная ревматология. 2014;8(1):73–6. [Alekseeva LI, Sharapova EP, Kashevarova NG, et al. The use of new aceclofenac dosage forms in patients with osteoarthrosis in real-life clinical practice. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2014;8(1):73–6. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1996-7012-2014-1-73-76

Διαθεσιμότητα: https://mrj.ima-press.net/mrj/article/view/641
https://doi.org/10.14412/1996-7012-2015-3-61-69

АНАЛЬГЕТИЧЕСКОЕ ЛЕЧЕНИЕ С ИСПОЛЬЗОВАНИЕМ СИСТЕМНОГО АЛГОРИТМА

Συγγραφείς: КАРАТЕЕВ АНДРЕЙ ЕВГЕНЬЕВИЧ, АЛЕКСЕЕВА Л.И.

Θεματικοί όροι: МЫШЕЧНО-СКЕЛЕТНАЯ БОЛЬ, ОСТЕОАРТРОЗ, НЕСПЕЦИФИЧЕСКАЯ БОЛЬ В НИЖНЕЙ ЧАСТИ СПИНЫ, РЕВМАТИЧЕСКАЯ ПАТОЛОГИЯ ОКОЛОСУСТАВНЫХ МЯГКИХ ТКАНЕЙ, ЦЕНТРАЛЬНАЯ СЕНСИТИЗАЦИЯ, АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ, НЕСТЕРОИДНЫЕ ПРОТИВОВОСПАЛИТЕЛЬНЫЕ ПРЕПАРАТЫ, ПАРАЦЕТАМОЛ, ТРАМАДОЛ, МИОРЕЛАКСАНТЫ, МЕДЛЕННОДЕЙСТВУЮЩИЕ СИМПТОМАТИЧЕСКИЕ СРЕДСТВА, ГЛЮКОКОРТИКОИДЫ, ЛОКАЛЬНЫЕ ИНЪЕКЦИИ, ДУЛОКСЕТИН, ПРЕГАБАЛИН

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/analgeticheskoe-lechenie-s-ispolzovaniem-sistemnogo-algoritma
http://cyberleninka.ru/article_covers/15845734.png

ОБОРОТ НАРКОТИЧЕСКИХ СРЕДСТВ И ПСИХОТРОПНЫХ ВЕЩЕСТВ. ВЗГЛЯД НА ПРОБЛЕМУ В РОССИЙСКОЙ ФЕДЕРАЦИИ

Συγγραφείς: МИКАЭЛЯН МАРИНА ФИЛИППОВНА

Θεματικοί όροι: НАРКОТИЧЕСКИЕ СРЕДСТВА,DRUGS,ПСИХОТРОПНЫЕ ВЕЩЕСТВА,PSYCHOTROPIC SUBSTANCES,МЕЖДУНАРОДНО-ПРАВОВОЕ РЕГУЛИРОВАНИЕ,INTERNATIONAL LEGAL REGULATION,КОНВЕНЦИИ,CONVENTION,СИСТЕМА НАЦИОНАЛЬНОГО КОНТРОЛЯ,THE SYSTEM OF THE NATIONAL CONTROL,АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ,ANALGESIC THERAPY

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/oborot-narkoticheskih-sredstv-i-psihotropnyh-veschestv-vzglyad-na-problemu-v-rossiyskoy-federatsii
http://cyberleninka.ru/article_covers/16167232.png

ОБЩИЕ ПРИНЦИПЫ ЛЕЧЕНИЯ СКЕЛЕТНО-МЫШЕЧНОЙ БОЛИ: МЕЖДИСЦИПЛИНАРНЫЙ КОНСЕНСУС

Πηγή: Научно-практическая ревматология.

Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, СКЕЛЕТНО-МЫШЕЧНАЯ БОЛЬ,ОСТЕОАРТРОЗ,НЕСПЕЦИФИЧЕСКАЯ БОЛЬ В СПИНЕ,АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ,МЕЖДИСЦИПЛИНАРНЫЙ КОНСЕНСУС,MUSCULOSKELETAL PAIN,OSTEOARTHRITIS,NONSPECIFIC BACK PAIN,ANALGESIC THERAPY,INTERDISCIPLINARY CONSENSUS, 3. Good health

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article/n/obschie-printsipy-lecheniya-skeletno-myshechnoy-boli-mezhdistsiplinarnyy-konsensus
http://cyberleninka.ru/article_covers/17022533.png

НЕСПЕЦИФИЧЕСКАЯ БОЛЬ В ПОЯСНИЧНО-КРЕСТЦОВОЙ ОБЛАСТИ: КЛИНИЧЕСКИЕ ОСОБЕННОСТИ И ПОДХОДЫ К МЕДИКАМЕНТОЗНОЙ ТЕРАПИИ (ПО МАТЕРИАЛАМ ЕВРОПЕЙСКИХ РЕКОМЕНДАЦИЙ ПО ЛЕЧЕНИЮ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В ПОЯСНИЧНО-КРЕСТЦОВОЙ ОБЛАСТИ)

Συγγραφείς: Раскина, Татьяна, Королева, М.

Θεματικοί όροι: БОЛЬ В ПОЯСНИЧНО-КРЕСТЦОВОЙ ОБЛАСТИ, АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ, СИРДАЛУД

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/nespetsificheskaya-bol-v-poyasnichno-kresttsovoy-oblasti-klinicheskie-osobennosti-i-podhody-k-medikamentoznoy-terapii-po-materialam
http://cyberleninka.ru/article_covers/14045935.png

Догоспитальная медицинская помощь при травмах с позиций анестезиологии реаниматологии

Συγγραφείς: МАКАЕВА Э.Х.

Θεματικοί όροι: ИНГАЛЯЦИЯ КИСЛОРОДА,ИСКУССТВЕННАЯ ВЕНТИЛЯЦИЯ ЛЕГКИХ,ИНФУЗИОННАЯ И АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ,ЗАКРЫТЫЙ МАССАЖ СЕРДЦА,ДЕФИБРИЛЯЦИЯ,ТРАВМЫ

Περιγραφή αρχείου: text/html

Διαθεσιμότητα: http://cyberleninka.ru/article/n/dogospitalnaya-meditsinskaya-pomosch-pri-travmah-s-pozitsiy-anesteziologii-reanimatologii
http://cyberleninka.ru/article_covers/16507382.png

Анальгетическое лечение с использованием системного алгоритма

Πηγή: Современная ревматология.

Θεματικοί όροι: 03 medical and health sciences, МЫШЕЧНО-СКЕЛЕТНАЯ БОЛЬ, ОСТЕОАРТРОЗ, НЕСПЕЦИФИЧЕСКАЯ БОЛЬ В НИЖНЕЙ ЧАСТИ СПИНЫ, РЕВМАТИЧЕСКАЯ ПАТОЛОГИЯ ОКОЛОСУСТАВНЫХ МЯГКИХ ТКАНЕЙ, ЦЕНТРАЛЬНАЯ СЕНСИТИЗАЦИЯ, АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ, НЕСТЕРОИДНЫЕ ПРОТИВОВОСПАЛИТЕЛЬНЫЕ ПРЕПАРАТЫ, ПАРАЦЕТАМОЛ, ТРАМАДОЛ, МИОРЕЛАКСАНТЫ, МЕДЛЕННОДЕЙСТВУЮЩИЕ СИМПТОМАТИЧЕСКИЕ СРЕДСТВА, ГЛЮКОКОРТИКОИДЫ, ЛОКАЛЬНЫЕ ИНЪЕКЦИИ, ДУЛОКСЕТИН, ПРЕГАБАЛИН, 0302 clinical medicine, 3. Good health

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article/n/analgeticheskoe-lechenie-s-ispolzovaniem-sistemnogo-algoritma
http://cyberleninka.ru/article_covers/15845734.png

Оборот наркотических средств и психотропных веществ. Взгляд на проблему в Российской Федерации

Πηγή: Вестник Волгоградского государственного медицинского университета.

Θεματικοί όροι: НАРКОТИЧЕСКИЕ СРЕДСТВА,DRUGS,ПСИХОТРОПНЫЕ ВЕЩЕСТВА,PSYCHOTROPIC SUBSTANCES,МЕЖДУНАРОДНО-ПРАВОВОЕ РЕГУЛИРОВАНИЕ,INTERNATIONAL LEGAL REGULATION,КОНВЕНЦИИ,CONVENTION,СИСТЕМА НАЦИОНАЛЬНОГО КОНТРОЛЯ,THE SYSTEM OF THE NATIONAL CONTROL,АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ,ANALGESIC THERAPY, 3. Good health

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article/n/oborot-narkoticheskih-sredstv-i-psihotropnyh-veschestv-vzglyad-na-problemu-v-rossiyskoy-federatsii
http://cyberleninka.ru/article_covers/16167232.png

Неспецифическая боль в пояснично-крестцовой области: клинические особенности и подходы к медикаментозной терапии (по материалам европейских рекомендаций по лечению неспецифической боли в пояснично-крестцовой области)

Πηγή: Современная ревматология.

Θεματικοί όροι: БОЛЬ В ПОЯСНИЧНО-КРЕСТЦОВОЙ ОБЛАСТИ, АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ, СИРДАЛУД

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article/n/nespetsificheskaya-bol-v-poyasnichno-kresttsovoy-oblasti-klinicheskie-osobennosti-i-podhody-k-medikamentoznoy-terapii-po-materialam
http://cyberleninka.ru/article_covers/14045935.png

Догоспитальная медицинская помощь при травмах с позиций анестезиологии реаниматологии

Πηγή: Научные и образовательные проблемы гражданской защиты.

Θεματικοί όροι: ИНГАЛЯЦИЯ КИСЛОРОДА,ИСКУССТВЕННАЯ ВЕНТИЛЯЦИЯ ЛЕГКИХ,ИНФУЗИОННАЯ И АНАЛЬГЕТИЧЕСКАЯ ТЕРАПИЯ,ЗАКРЫТЫЙ МАССАЖ СЕРДЦА,ДЕФИБРИЛЯЦИЯ,ТРАВМЫ

Περιγραφή αρχείου: text/html

Σύνδεσμος πρόσβασης: http://cyberleninka.ru/article/n/dogospitalnaya-meditsinskaya-pomosch-pri-travmah-s-pozitsiy-anesteziologii-reanimatologii
http://cyberleninka.ru/article_covers/16507382.png

Cytokine gene polymorphisms as predictors of chronic pain syndrome in oncology ; Генетический полиморфизм цитокинов как предиктор фенотипической реализации хронического болевого синдрома в онкологии

Συγγραφείς: Bobrova O.P., Shnayder N.A., Petrova M.M., Zyryanov K.S., Sychev D.A.

Πηγή: Siberian Journal of Oncology

Θεματικοί όροι: chronic pain, Single nucleotide polymorphisms (SNPs), analgesic therapy, review, TNF-α, Il-1, Il-6, Il-10, pharmacogenetics, nociception, cytokine receptors, oncology, хронический болевой синдром, однонуклеотидный полиморфизм (ОНП), анальгетическая терапия, обзор, фНО-α, фармакогенетика, ноцицепция, цитокиновые рецепторы

Relation: https://repository.rudn.ru/records/article/record/145700/

Διαθεσιμότητα: https://repository.rudn.ru/records/article/record/145700/